fluorodeoxyglucose f18 has been researched along with Skin Neoplasms in 352 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 13 (3.69) | 18.2507 |
2000's | 113 (32.10) | 29.6817 |
2010's | 165 (46.88) | 24.3611 |
2020's | 61 (17.33) | 2.80 |
Authors | Studies |
---|---|
Jiang, JY; Karikios, D; Lee, ME; Mansberg, R; Parry, NM | 1 |
Abgral, R; Salaun, PY; Sassolas, B | 1 |
Amaya, S; Minami, T; Mitsui, T; Munemoto, Y; Nakanuma, Y; Saito, K; Shimada, M; Takashima, Y; Terada, T; Yamagishi, Y | 1 |
Callahan, J; Cardin, A; Cavanagh, K; Hicks, RJ; Lim, AM; McLean, LS; Rischin, D; Xie, J | 1 |
Abdullayev, G; Aliyev, JA; Çiftçioğlu, MA; Mehdi, E; Novruzov, F | 1 |
Chen, L; Cornelius, LA; Fields, RC; Jaeger, ZJ; Mhlanga, JC; Williams, GA | 1 |
Abbatepaolo, C; Arezzo, F; Bellitti, E; Cazzato, G; Cimmino, A; Colagrande, A; Cormio, G; Foti, C; Ingravallo, G; Lettini, T; Loizzi, V; Lospalluti, L; Resta, L; Romita, P; Rossi, R; Sablone, S | 1 |
Aide, N; Alipour, R; Hicks, RJ; Iravani, A; Kottler, D; Prigent, K | 1 |
Andersen, JAS; Bastholt, L; Gerke, O; Grupe, P; Hess, S; Hildebrandt, MG; Holdgaard, PC; Spatzek, AD; Vilstrup, MH | 1 |
Antke, C; Emil, N; Giesel, FL; Lawal, I; Mokoala, K; Sathekge, M | 1 |
Guo, H; He, X; Hou, Y; Yi, H; Yu, J | 1 |
Bachmann, IM; Haslerud, TM; Helgeland, L; Karlsdottir, Å; Reikvam, H; Thunestvedt, LMØ | 1 |
Aalbersberg, EA; Blankenstein, SA; Haanen, JB; Klop, WMC; Stokkel, MPM; van Akkooi, ACJ; van de Wiel, BA; van der Hiel, B; Wondergem, M | 1 |
Rao, Z; Wang, Y; Wu, J; Zhang, C; Zhang, S | 1 |
Wang, L; Wu, H; Zhang, Y | 1 |
Chen, H; Chen, Y; Li, M; Liu, H; Yang, X | 1 |
Abouzian, S; Camacho, V; Carrió, I; Duch, J; Estorch, M; Fernández-León, A; Flotats, A; López-Mora, DA; Sabaté-Llobera, A; Sampedro, F; Sizova, M; Stefaneli, P | 1 |
Kim, SJ; Shim, SR | 1 |
Bastholt, L; Bidstrup, PE; Bojesen, S; Chakera, AH; Ellebæk, E; Helvind, NM; Hendel, HW; Hölmich, LR; Johansen, C; Kjærskov, MW; Petersen, SK; Skyum, H; Svane, IM; Weitemeyer, MB | 1 |
Hassan, A; Muzaffar, M | 1 |
Berberich, C; Gaa, J; Krackhardt, A; Mustafa, M; Nekolla, SG; Zhuwu, Y | 1 |
Dimitriou, F; Ensle, F; Huellner, MW; Maurer, A; Schaab, JA | 1 |
Ichikawa, R; Namiki, T; Tateishi, U; Tsuchiya, J; Yokoyama, K | 1 |
Ding, H; Fan, D; Huang, Z; Liu, Y; Wan, Z | 1 |
Durmus, O; Ergun, EL; Gokoz, O; Gulseren, D; Saglam, EA | 1 |
Chen, L; Feng, C; Li, K; Wang, C; Zhao, S | 1 |
Chen, KC; Chiu, YJ; Chu, PY; Li, CY; Wang, TH | 1 |
Burger, H; Holness, J; Twycross, SH | 1 |
Amitay-Laish, I; Bairey, O; Barzilai, A; Even-Sapir, E; Feinmesser, M; Feuerman, H; Hodak, E; Mimouni, D; Snast, I | 1 |
Barker, CA; Mahajan, S; Mauguen, A; Pandit-Taskar, N; Singh, B | 1 |
Albano, D; Alongi, P; Familiari, D; Fornito, MC; Galia, M; Ganduscio, G; Grassedonio, E; Laudicella, R; Messina, M; Midiri, M; Ruggeri, A; Scalisi, S; Spada, M | 1 |
Huynh, KN; Nguyen, BD | 1 |
Hicks, RJ; Iravani, A; Sandhu, S | 1 |
Aimn Working Group, Y; Annunziata, S; Caobelli, F; Laudicella, R; Pizzuto, DA | 1 |
Baldari, S; Baratto, L; Iagaru, A; Laudicella, R; Minutoli, F | 1 |
Castello, A; Lopci, E | 1 |
Bhargava, P; Flynt, L; Marcal, L | 1 |
Avci, N; Sengoz, T | 1 |
Korekawa, A; Nakajima, K; Nakano, H; Sawamura, D | 1 |
Altun, GD; Taş, A; Taştekin, E; Üstün, F | 1 |
Ammari, S; Antonios, L; Dercle, L; Deutsch, E; Gómez, RGH; Marabelle, A; Moya-Plana, A; Robert, C; Saenger, Y; Schwartz, LH; Seban, RD; Yeh, R | 1 |
Dejust, S; Durot, E; Grange, F; Morland, D; Papathanassiou, D | 1 |
Hindié, E | 1 |
Baynosa, J; Cheng, D; De Guzman, MD; Doyle, GM; Jones, MS; Kirgan, D; McNicoll, CF; Rivera, MR; St Hill, CR | 1 |
Lin, K; Miao, W; Xue, Q; Zheng, J | 1 |
Aoyama, Y; Fukuzawa, T; Hashimoto, J; Ichikawa, T; Ikoma, H; Kajiwara, H; Kazama, T; Kodama, E; Kuroki, T; Mabuchi, T; Mikami, T; Nagafuji, Y; Nagao, R; Sekiguchi, Y | 1 |
Annovazzi, A; Annunziata, S; Bergomi, S; Pasqualoni, R; Sciuto, R | 1 |
Bi, H; Dong, A; Ji, X | 1 |
Calabretta, R; Hacker, M; Haug, A; Hoeller, C; Karanikas, G; Li, X; Mitterhauser, M; Pichler, V | 1 |
Álamo-de-la-Gala, MDC; Calvo-Morón, MC; García-Gómez, FJ; León-Asuero-Moreno, I; Ríos-Martín, JJ | 1 |
Barat, M; Barret, M; Cottereau, AS; Dohan, A; Gaujoux, S; Guegan-Bart, S; Guillo, E; Hoeffel, C; Soyer, P | 1 |
Baffour, FI; Bartlett, DJ; Broski, SM; Erie, AJ; Glazebrook, KN | 1 |
Bodet, D; García-Patos, V; González-Cruz, C; Muñoz-Couselo, E | 1 |
Kan, Y; Lu, X; Wang, W; Yang, J | 1 |
In, GK; Jadvar, H | 1 |
Hara, A; Kato, H; Kawaguchi, M; Matsuo, M; Matsuyama, K; Miyazaki, T; Seishima, M; Suzui, N; Tomita, H | 1 |
Czech, N; Forschner, A; Franzius, C; Garbe, C; Gutzmer, R; Matiszick, A; Meier, F; Sachse, MM; Schüssler, F; Völker, C; Wagner, G | 1 |
Chen, C; Hu, X; Huang, Q; Jiang, M; Tang, Y | 1 |
Fahy, AS; Jakub, JW; MacArthur, TA | 1 |
Been, LB; Brabander, T; Grünhagen, DJ; Lemstra, C; Mooyaart, AL; Mulder, EEAP; Stahlie, EHA; van Akkooi, ACJ; van der Veldt, AAM; Vegt, E; Verburg, FA; Verhoef, C; Verver, D | 1 |
Ghezzi, CL; Schneider Galvão, G; Schuch, A; Torres, L | 1 |
Contreras, C; Knopp, MV; Miller, ED; Wright, CL | 1 |
Castro, AC; Mamede, M; Paulino, E; Ribeiro, TH; S, R | 1 |
Kang, S; Park, I | 1 |
Hwang, JP | 1 |
Bagot, M; Brice, P; La Selva, R; Ram-Wolff, C; Vercellino, L | 1 |
Chen, H; Fu, H; Guo, X; Wu, H | 1 |
Cheedella, N; Hinson, S; Li, L; Lucas, E; Molberg, K; Thibodeaux, J | 1 |
Arsenault, F; Plouznikoff, N | 1 |
Di Loreto, M; Francis, R | 1 |
Choy, I; Saw, RPM; Thompson, JF; Young, CJ; Zahid, A | 1 |
Cayci, Z; Khaja, S; Li, F; Ozturk, K; Rischall, M; Ustun, C | 1 |
Hata, H; Hirata, K; Imafuku, K; Inamura-Takashima, Y; Ishida, Y; Kitamura, S; Otsuka, A; Shimizu, H; Uehara, J; Yanagi, T | 1 |
Estall, V; Hruby, G; Kumar, M; Macfarlane, D; Poulsen, M; Pullar, A; Rischin, D; Tripcony, L; Veness, M | 1 |
Anwar, H; Dimitrakopoulou-Strauss, A; Haberkorn, U; Hassel, JC; Kopp-Schneider, A; Larribere, L; Sachpekidis, C; Winkler, J | 1 |
Alharbi, AA; Aljared, A; Huellner, MW | 1 |
Avery, R; Eshghi, N; Kuo, PH; Lundeen, TF; MacKinnon, L | 1 |
Hatanaka, Y; Hokkoku, K; Matsukura, K; Sasajima, Y; Shiraoka, A; Sonoo, M; Tada, Y; Takahashi, Y; Yang, L | 1 |
Asioli, S; Dalpiaz, G; Fanti, S; Marchiori, E; Rea, G | 1 |
Fang, Y; Liu, T; Ma, PQ; Sun, C; Xu, LB; Xu, SF; Yu, SJ; Zhang, WJ; Zhang, XX; Zhao, ZG | 1 |
Dika, E; Diodato, S; Fanti, S; Gardini, A; Lambertini, M; Patrizi, A; Ravaioli, GM; Veronesi, G; Zannetti, G | 1 |
Curchin, C; Robinson, M; Soyer, HP | 1 |
Been, LB; Faut, M; Hoekstra, HJ; Kruijff, S; van Ginkel, RJ; van Leeuwen, BL | 1 |
Kou, Y; Kuang, A; Liu, B; Shen, G | 1 |
McBean, R; Peng, L | 1 |
Ambrosini, V; Ardizzoni, A; Comito, F; Melotti, B; Sperandi, F | 1 |
Pincus, J | 1 |
Bermejo, J; Fornons-Servent, R; Marcoval, J; Sabaté-Llobera, A | 1 |
Imataki, O; Kadowaki, N; Uchida, S; Uemura, M; Yokokura, S | 1 |
Bernardo, A; D'Ambrosio, D; Licata, L; Trifirò, G; Vacchieri, I; Vellani, C | 1 |
Alavi, A; Baruch, E; Boursi, B; Eshet, Y; Gholami, S; Houshmand, S; Mamtani, R; Margalit, O; Markel, G; Mitchell, TC; Shacham-Shmueli, E; Werner, TJ; Yang, YX | 1 |
Fujita, Y; Hirata, K; Manabe, O; Natsuga, K; Shimizu, H | 1 |
Klinghuber, M; Müller, G; Pabst, A; Vandersee, S; Werkmeister, R | 1 |
Alfageme, F; Catalano, O; Koppula, V; Mandava, A; Wortsman, X | 1 |
Dimitrakopoulou-Strauss, A; Hakim-Meibodi, L; Hassel, JC; Kopp-Schneider, A; Sachpekidis, C | 1 |
Buset, CS; Dummer, R; Mangana, J | 1 |
Berkowitz, AS; Eliashar, R; Frenkel, S; Hirshoren, N; Neuman, T; Weinberger, JM | 1 |
Dong, A; Wang, Y; Xiao, Z | 1 |
Glitza Oliva, IC; Safa, H | 1 |
Harada, K; Irisawa, R; Kanzaki, A; Kiriyama, N; Maeda, T; Tsuboi, R | 1 |
Bates, BM; Beck, S; Bell, AH; Bowtell, DD; Browning, J; Byrne, DJ; Choong, DY; Desai, J; Etemadmoghadam, D; Fellowes, AP; Fox, SB; Iravani, A; Khoo, C; McEvoy, CR; Mileshkin, L; Nastevski, V; Prall, OW; San Leong, H; Smith, K; Tothill, RW; Xu, H | 1 |
Beddell, G; Ivanov, N; Vaiciunaite, D | 1 |
Fujii, T; Hishizawa, M; Inagaki, N; Kawaguchi-Sakita, N; Kim, YH; Kitamura, M; Kitawaki, T; Matsumoto, S; Nomura, M; Otsuka, A; Saito, R; Sakamori, Y; Sone, M; Taura, D; Yamasaki, T; Yamauchi, I; Yasoda, A | 1 |
Barker, CA; Mahajan, S; Pandit-Taskar, N; Singh, B | 1 |
Ali, Z; Koppula, V; Mandava, A; Yalamanchili, R | 1 |
Albright, RC; Manohar, S | 1 |
Gangadharan, VP; Jayasree, MG; Mahadevan, P; Pratap, T; Senthil, R; Visakh, RA | 1 |
Abgral, R; Alavi, Z; Amrane, K; Delcroix, O; Gouva, S; Keromnes, N; Le Goupil, D; Quere, G; Querellou, S; Salaun, PY; Schick, U | 1 |
Glatz, K; Itin, P; Ivanova, K; Nicolas, G; Zippelius, A | 1 |
di Lenardo, F; Epstude, M; Hug, U; Riklin, C; Strobel, K; Tornquist, K; Winterhalder, R | 1 |
Cribe, AS; Frederiksen, H; Friis, LS; Marcher, CW; Petersen, H; Steenhof, M | 1 |
Berlangieri, SU; Lee, ST; Scott, AM; Tan, GJ | 1 |
Bastiaannet, E; Bonenkamp, JJ; Hoekstra, HJ; Hoekstra, OS; Koelemij, R; Niebling, MG | 1 |
Antic, D; Mihaljevic, B; Pelemis, M; Perunicic, M; Petrovic, N; Stevanovic, G | 1 |
Bressel, M; Byrne, K; Callahan, J; Hicks, RJ; Jacobs, D; Laing, J; Macmanus, MP; Seel, M; Siva, S | 1 |
Ahronowitz, I; Hernandez Pampaloni, M; Ibrahim, SF; McCalmont, TH; Ryan, JL; Yu, SS | 1 |
Califano, I; Califano, L; Coduti, M; Otero, J; Quildrian, S; Rojas Bilbao, E | 1 |
Formstecher, P; Guerreschi, P; Huglo, D; Kluza, J; Marchetti, P; Martinot-Duquennoy, V; Mortier, L; Qassemyar, A; Ravasi, L; Scalbert, C | 1 |
Akashi, K; Hayashi, M; Iwasaki, H; Kato, K; Kikushige, Y; Kuroiwa, M; Miyamoto, T; Nakaike, T; Ohshima, K; Oku, S; Takenaka, K; Teshima, T | 1 |
Bikhchandani, J; Richards, AT; Smith, RB; Wood, J | 1 |
Giovanella, L; Kakhki, VR; Sadeghi, R; Treglia, G | 1 |
Altenbernd, J; Bockisch, A; Klode, J; Nagarajah, J; Rosenbaum-Krumme, S; Tekin, G; Wieder, HA | 1 |
Bourgeois, AC; Bradley, YC; Chang, TT; Fish, LM | 1 |
Adams-Huet, B; Anderson, J; Lazaga, FJ; Mathews, D; Oz, OK | 1 |
Behrendt, FF; Gray, BD; Kiessling, F; Lederle, W; Mottaghy, FM; Pak, KY; Palmowski, K; Palmowski, M; Rix, A | 1 |
Couturier, OF; Delva, R; George, A; Girault, S; Morel, O; Soulié, P; Testard, A | 1 |
Balogova, S; Metivier, D; Montravers, F; Talbot, JN | 1 |
Bar-Sela, G; Eran, A; Kaidar-Person, O | 1 |
Bodell, MA; Kraus, ES; Lipson, EJ; Sharfman, WH | 1 |
Fujiwara, H; Niiya, T; Suemori, K; Yasukawa, M | 1 |
Alabbas, H; Meguerditchian, AN; Ramjaun, A; Rodriguez Rivera, AM | 1 |
Dong, A; Wang, Y; Wen, W; Zhai, Z; Zuo, C | 1 |
Campbell, A; McCarthy, M; McIvor, J; Siew, T | 1 |
Juan, YH; Khandelwal, A; Krajewski, KM; Ramaiya, N; Saboo, SS; Shinagare, AB; Tirumani, SH | 1 |
Bowyer, SE; Hicks, RJ; Long, GV; Lyle, M; McArthur, GA; Millward, M; Raleigh, JM; Rao, AD; Sandhu, S | 1 |
Balaco, I; Barbosa, L; Brito, MJ; Noruegas, MJ | 1 |
Kagohashi, K; Kurishima, K; Satoh, H; Taguchi, S | 1 |
Hatazawa, J; Ikeda, H; Kanai, Y; Kato, K; Ogata, Y; Watabe, H; Watabe, T; Yamamoto, S | 1 |
Dave, SR; Pucar, D; Samuel, TA; Savage, N; Williams, HT | 1 |
Collins, GP; Corcoran, JP; Davies, SJ; Ho, LP; Moore, AJ | 1 |
Bagaria, SP; Etzioni, D; Gray, RJ; Haddad, D; Pockaj, BA; Wasif, N | 1 |
Ahmad, MW; Alken, S; Colleran, GC; Fitzpatrick, D; Kavanagh, EC; Kelly, CM; Lyons, TG; Murray, B; O'Kane, GM | 1 |
Akiyama, M; Ichimura, K; Iwatsuki, K; Shiomi, M; Yamaguchi, M; Yamasaki, O | 1 |
Li, ZG; Qin, XJ | 1 |
Fotos, JS; Sogge, SM; Tulchinsky, M | 1 |
Barker, DW; Gru, AA; Natwa, M; Samarghandi, A | 1 |
Emri, G; Erdei, I; Fedinecz, N; Galuska, L; Gellén, E; Janka, E; Juhász, I; Lukács, R; Péter, Z; Remenyik, É; Sántha, O | 1 |
Akhtar, S; Alhuraiji, A | 1 |
Rohren, EM | 1 |
Duman, G; Güner, A; Karyağar, S; Kece, C; Kesici, U; Küçütulu, U | 1 |
Chin-Lenn, L; McKinnon, JG; Teman, CJ; Urbanellis, P | 1 |
Chang-Hong, L; Dan, S; Qiang, G; Shu-Xia, W | 1 |
Chiba, S; Fujishima, F; Hasegawa, Y; Ichinohasama, R; Ito, Y; Kurita, N; Kyogoku, C; Miyamoto, K; Nakamura, S; Obara, N; Ogawa, S; Sakata-Yanagimoto, M; Seki, M; Yokoyama, Y | 1 |
Bressel, M; Byrne, K; Callahan, J; Chait, L; Hicks, RJ; MacManus, MP; Seel, M; Siva, S | 1 |
Eigentler, TK; Garbe, C; la Fougère, C; Nikolaou, K; Pfannenberg, C; Schüle, SC | 1 |
Alavi, A; Fardin, S; Gholami, S; Rook, AH; Samimi, S | 1 |
Howle, J; Larcos, G; Liu, J; Veness, M | 1 |
Hu, S; Liu, C; Liu, R; Liu, X; Wang, M; Zhang, Y | 1 |
Ahlawat, S; Baig, A; Blakeley, JO; Fayad, LM; Jacobs, MA | 1 |
Ahn, BC; Jeong, SY; Kang, SM; Lee, J; Lee, SJ; Lee, SW; Son, SH | 1 |
Fujiwara, M; Fukamizu, H; Suzuki, T; Takiguchi, T; Tokura, Y | 1 |
Ben-Haim, S; Davidson, T; Epelbaum, R; Garkaby, J; Goshen, E; Israel, O; Primashvili, N; Shapira, R | 1 |
Miura, K; Namiki, T; Nojima, K; Tanaka, K; Tanaka, M; Ueno, M; Yokozeki, H | 1 |
Abdelatif, B; Amal, G; Ghita, B; Ghofrane, CS; Majdouline, H; Malika, AI; Nabil, C; Najoua, T; Sara, T; Souha, S; Zineb, B | 1 |
Mena, E; Mirpour, S; Sheikhbahaei, S; Subramaniam, RM; Taghipour, M; Xiao, J | 1 |
Hsieh, TC; Kao, CH; Liao, CW; Yen, KY | 1 |
Conrad, F; Freesmeyer, M; Goetze, S; Kaatz, M; Winkens, T | 1 |
Giordano, S; Kemppainen, J; Koskivuo, I; Minn, H; Seppänen, M; Veräjänkorva, E; Vihinen, P | 1 |
Chen, Y; Li, J; Qiu, L; Tu, G | 1 |
Ganti, R; Peng, F; Wachsmann, JW | 1 |
Chen, J; Chen, X; Guan, L; Liu, Y; Pang, H; Wang, J; Xu, L; Zhu, J | 1 |
Boshomane, T; Lawal, I; Lengana, T; Modiselle, M; Ololade, K; Reyneke, F; Sathekge, M; Vorster, M | 1 |
Matsuda, M; Sueda, S; Taniguchi, T | 1 |
Fujiwara, M; Fukamizu, H; Senoo, A; Suzuki, T; Tokura, Y | 1 |
Borkar, S; Pandit-Taskar, N | 1 |
Chung, DK; Ho Shon, IA; Saw, RP; Thompson, JF | 1 |
Ahmadzadehfar, H; Biersack, HJ; Ezziddin, S; Palmedo, H; Reinhardt, M; Singh, B; Strunk, H; Tüting, T | 1 |
Geller, MD; Gerard, PS; Mattern, M | 1 |
Basset-Seguin, N; Filmont, JE; Groheux, D; Hindié, E; Kerob, D; Lebbé, C; Moretti, JL; Sarandi, F; Teyton, P; Toubert, ME | 1 |
Baurain, JF; Crott, R; Krug, B; Lonneux, M; Pirson, AS; Vander Borght, T | 1 |
Brenot-Rossi, I; Chuto, G; Gaudy-Marqueste, C; Grob, JJ; Nicol, I; Richard, MA | 1 |
Becherer, A; Czerny, C; Dawid, M; Dudczak, R; Kletter, K; Mueller-Mang, C; Novotny, C; Peloschek, P; Sailer, J; Weber, M | 1 |
Antoch, G; Beyer, T; Bockisch, A; Dahmen, G; Jablonka, R; Kuehl, H; Rosenbaum, S; Veit-Haibach, P; Vogt, FM | 1 |
Chen, HD; He, CD; Liu, M; Shan, SJ; Wei, HC; Wu, J; Xiao, T; Yin, YF | 1 |
Erickson, LA; Farley, DR; Flotte, TJ; Jakub, JW; Kottschade, LA; Markovic, SN; McWilliams, RR; Olivier, KR; Pittelkow, MR; Pulido, JS; Quevedo, JF; Schild, SE; Sekulic, A; Stoian, I; Tran, NV; Vile, RG; Vuk-Pavlovic, S; Weenig, RH; Wiseman, GA | 1 |
Denecke, T; Rothe, JH; Röttgen, R | 1 |
Altaner, S; Demir, MK; Gençhallaç, H; Kartal, O; Ozdemir, H | 1 |
Amrouche, L; Bourgarit, A; Farge, D; Florea, L; George, C; Gornet, JM; Lascoux, C; Séréni, D | 1 |
Bode, B; Dummer, R; Fischer, DR; Goldinger, S; Imhof, L; Steinert, HC; Strobel, K; Veit-Haibach, P; von Schulthess, GK | 1 |
Slaby, J; Suri, U | 1 |
Bastiaannet, E; Hoekstra, HJ; Kobold, AC; Kruijff, S; Suurmeijer, AJ; van Ginkel, RJ | 1 |
Basu, S; Lad, S; Ramani, SK | 1 |
Carreras-Delgado, JL; Delgado-Bolton, RC; Fernández-Pérez, C; Gambhir, SS; Jiménez-Requena, F; Pérez-Vázquez, JM; Schwimmer, J | 1 |
Joo, SY; Ko, HM; Lee, BK; Lee, NH; Seo, YH | 1 |
Antoch, G; Bockisch, A; Eberhardt, W; Esser, S; Forsting, M; Gölitz, P; Hamami, M; Heusner, T | 1 |
Hatmaker, AR; Holt, GE; Kelley, MC; Mansour, AA; Schwartz, HS | 1 |
Baurain, JF; Beguin, C; Crott, R; Krug, B; Lonneux, M; Pirson, AS; Roch, I; Vander Borght, T | 1 |
Concannon, R; Larcos, GS; Veness, M | 1 |
Hyun, IY; Yun, MY | 1 |
Dai, W; Feng, X; Guan, Y; Hua, F; Zhao, J | 1 |
Cicin, I; Ozpaçac, T; Ozülker, F; Ozülker, T | 1 |
Bonnichon-Py, A; Foehrenbach, H; Le Floch, H; Mairovitz, A; Margery, J; Marotel, C; Pons, F; Rivière, F; Salles, Y; Staub, E; Vaylet, F | 1 |
Aukema, TS; Bonfrer, JM; Korse, CM; Kroon, BB; Nieweg, OE; Olmos, RA; Vogel, WV; Wouters, MW | 1 |
Fischer, SM; Herschman, HR; Huang, SC; Ishikawa, TO; Kumar, IP; Kusewitt, D; Machado, HB; Wong, KP | 1 |
Boeing, C; Dissemond, J; Grabbe, S; Hillen, U; Klode, J; Poeppel, T | 1 |
Karyagar, S; Karyagar, SS; Kece, C; Ozdil, B | 1 |
Berger, F; Pfluger, T; Reiser, MF; Schramm, N | 1 |
Horn, J; Lock-Andersen, J; Loft, A; Sjøstrand, H | 1 |
Crott, R; Krug, B; Pirson, AS; Vander Borght, T | 1 |
Lisbona, R; Makis, W | 1 |
Jeong, HJ; Jeong, YJ; Kim, DW; Kim, JS; Kwak, JY; Lim, ST; Sohn, MH; Yim, CY | 1 |
Kang, BT; Kang, MH; Kim, DY; Lim, CY; Park, HM | 1 |
Hafner, J | 1 |
Minn, H; Vihinen, P | 1 |
Ahn, BC; Hong, CM; Jeong, SY; Kang, S; Lee, HJ; Lee, J; Lee, SJ; Lee, SW; Song, BI | 1 |
Bastiaannet, E; Brouwers, AH; Hoekstra, HJ; Kobold, AC; Kruijff, S; Speijers, MJ | 1 |
Fulham, M; Prakoso, E; Selby, WS; Thompson, JF | 1 |
Chevreau, C; Courbon, F; Julian, A; Meyer, N; Payoux, P; Wagner, T; Zerdoud, S | 1 |
Lindskog, DM; Nikkhou, K; Talusan, P | 1 |
Clapp, AJ; Peller, PJ; Subramaniam, RM | 1 |
Gutzeit, A; Jacob, AL; Kos, S; Menter, T; Schubert, T; Takes, M | 1 |
Abbott, RA; Acland, KM; Harries, M; O'Doherty, M | 1 |
Chung, D; Howman-Giles, R; Thompson, JF; Uren, RF | 1 |
Bastiaannet, E; Brouwers, AH; Hoekstra, HJ; Hospers, GA; Kruijff, S; Nagengast, WB; Speijers, MJ; Suurmeijer, AJ | 1 |
Cho, SB; Kim, JS; Lee, JH; Lee, SH; Zheng, Z | 1 |
Celen, Z; Erkilic, S; Kalender, E; Yilmaz, M | 1 |
Collyer, JC; Ghazali, N; Tighe, J | 1 |
Balasubramanian Harisankar, CN; Bhattacharya, A; Kashyap, R; Malhotra, P; Manohar, K; Rai Mittal, B; Singh, B; Varma, S | 1 |
Hoefnagel, K; Olmos, RV; Stokkel, MP; van der Hiel, B | 1 |
Bastiaannet, E; Brouwers, AH; Hoekstra, HJ; Hoekstra, OS; Oyen, W; Thompson, JF; Uyl-de Groot, CA; van der Jagt, EJ; van Ooijen, B; Verzijlbergen, F | 1 |
Millward, MJ | 1 |
Amaravadi, R; Callahan, J; Chapman, P; Flaherty, KT; Hicks, RJ; Kim, KB; Lee, RJ; McArthur, GA; Nolop, K; Puzanov, I; Ribas, A; Sosman, JA | 1 |
Nguyen, BD; Nguyen, VX; Ram, PC | 1 |
Allan, C; Barbour, A; Bayley, G; Burmeister, B; Burmeister, E; Dwyer, P; Foote, M; Lambie, D; Meakin, J; Pullar, A; Smithers, M; Thomas, J | 1 |
Herold, CJ; Karanikas, G; Mayerhoefer, ME; Prosch, H; Weber, M | 1 |
Abernethy, AP; Beasley, GM; Broadwater, G; Eikman, EA; Marzban, S; Parsons, C; Salama, AK; Selim, MA; Tyler, DS; Wong, T; Zager, JS | 1 |
Attias, D; Polliack, A; Tadmor, T | 1 |
Biko, DM; Greene, G; Mezheritskiy, I | 1 |
Aerts, MA; De Looze, D; Mana, F; Neyns, B; Reenaers, C; Urbain, D | 1 |
Kasami, M; Uematsu, T | 1 |
Fujita, H; Minatani, Y; Miyagaki, T; Ohmatsu, H; Ohno, Y; Sato, S; Sugaya, M; Sumida, H; Uwajima, Y; Yamashita, H | 1 |
Han, YM; Hwang, DH; Hwang, HS; Kang, IW; Ko, Y; Lee, ES; Lee, GK | 1 |
Baumert, BG; Kleijnen, J; Sauerland, S; Scheibler, FJ; Schröer-Günther, MA; Schürmann, C; Westwood, ME; Wolff, RF | 1 |
Berthezene, Y; Bracoud, L; Durupt, F; Giammarile, F; Journe, C; Jouvet, JC; Morelec, I; Thomas, L; Thomson, V; Yanes, M | 1 |
Baldwin, J; Blaydorn, L; Downhour, M; Hoff, DD; Korn, RL; Thacker, CA; Tibes, R; Weiss, GJ; White, E | 1 |
Bender, H; Biersack, HJ; Frohmann, JP; Grünwald, F; Kensy, J; Reinhardt, MJ; Reinhold, U; Willkomm, P | 1 |
Aigner, RM; Richtig, E; Schwarz, T | 1 |
Lentz, SS | 1 |
Berner, U; Diehl, M; Döbert, N; Grünwald, F; Hamscho, N; Ludwig, R; Menzel, C | 1 |
Becherer, A; Hoffmann, M; Kletter, K; Oberhuber, G; Raderer, M | 1 |
Dupont, P; Garmyn, M; Gysen, M; Hoe, LV; Mortelmans, L; Stas, M; Stroobants, S; Wever, ID | 1 |
Agress, H; Felig, DM; Sedarat, A; Waintraub, SE | 1 |
Cobben, DC; Elsinga, PH; Hoekstra, HJ; Jager, PL; Koopal, S; Tiebosch, AT; Wobbes, T | 1 |
Galen, B; Gourgiotis, L; Guthrie, LC; Patronas, NJ; Reynolds, JC; Sarlis, NJ; Shawker, TH; Skarulis, MC | 1 |
Nguyen, BD | 1 |
Carlson, KA; Davidson, D; Hutchins, GD; Jung, SH; Schauwecker, DS; Siddiqui, AR; Wagner, JD | 1 |
Bueno, C; Carreras, JL; Lázaro, P; Longo, MI; Montz, R | 1 |
Wagner, JD | 2 |
Boisgard, R; Bouet, S; Frelat, G; Geffrotin, C; Horak, V; Le Chalony, C; Leplat, JJ; Tavitian, B; Tricaud, Y; Vincent-Naulleau, S | 1 |
Bourguet, P | 1 |
Cho, SB; Chung, KY; Jung, J; Lee, KH; Yun, M | 1 |
Coleman, RE; Kitapci, MT | 1 |
Franzius, Ch; Löffler, M; Nashan, D; Schober, O; Weckesser, M | 1 |
Cook, TF; Fosko, SW; Hu, W; Lowe, VJ | 1 |
Cobben, DC; Havenga, K; Hoekstra, HJ; Nienhuijs, S; Oyen, WJ; Ruers, TJ; Wobbes, T | 1 |
Becherer, A; Der-Petrossian, M; Hoffmann, M; Raderer, M; Trautinger, F; Valencak, J | 1 |
Boán, JF; Redondo, P | 1 |
Grasee, EA; Wagner, JD | 1 |
Conrad, GR; Holzhauer, M; Sinha, P | 1 |
Friedman, KP; Wahl, RL | 1 |
Berchem, G; Decker, G; Lasar, Y; Pilloy, W; Snen, M | 1 |
Schöder, H; Weng, LJ | 1 |
Chang, CP; Chu, YK; Hsieh, HJ; Lin, SH; Liu, RS | 1 |
Alavi, A; Bural, G; Kumar, R; Mavi, A | 1 |
Alavi, A; Kumar, R | 1 |
Buatti, JM; Funk, GF; Graham, MM; Hoffman, HT; Smith, RB; Yao, M | 1 |
Cho, SB; Chung, KY; Chung, WG; Lee, JD; Lee, MG; Yun, M | 1 |
Coleman, JJ; Daggy, J; Davidson, D; Hutchins, G; Logan, T; Love, C; Schauwecker, D; Wagner, JD; Wenck, S | 1 |
Grosu, AL; Nieder, C | 1 |
Bastiaannet, E; Hoekstra, HJ; Hoekstra, OS; Jager, PL; Meijer, S; Oyen, WJ; Wobbes, T | 1 |
Müller, SP | 1 |
Akhurst, T; Brady, MS; Gonen, M; Hilton, S; Larson, S; Patel, A; Spanknebel, K | 1 |
Bieber, T; Biersack, HJ; Bucerius, J; Huber, A; Jaeger, U; Joe, AY; Matthies, A; Reinhardt, MJ; Roedel, R; Strunk, H; Tüting, T | 1 |
Clark, PB; Kraas, J; Levine, EA; Shen, P; Soo, V | 1 |
Civelek, AC; Khayyat, N; Memisoglu, E; Naunheim, KS; Osman, MM; Piotrowski, B; Reimers, HJ | 1 |
Balan, K; Seshadri, N; Wat, J | 1 |
Cangelosi, CJ; Lin, YG; Musana, KA; Raja, S | 1 |
Bastiaannet, E; Hoekstra, HJ; Hoekstra, OS; Jager, PL; Oyen, WJ; Wobbes, T | 1 |
Erasmus, JJ; Gershenwald, JE; Macapinlac, H; Pawlik, TM; Ross, MI; Truong, MT | 1 |
Belhocine, T; Bolle, S; Dargent, JL; Flamen, P; Frühling, J; Hustinx, R; Letesson, G; Pierard, GE; Rigo, P | 1 |
Alavi, A; Kumar, R; Xiu, Y; Zhuang, HM | 1 |
Gambhir, SS; Quon, A; Vasanawala, MS; Wang, Y | 1 |
Miranda, EP | 1 |
Albertini, AF; Devaux, JY; Ech-Charraq, I; Hindié, E; Weinmann, P; Zanotti-Fregonara, P | 1 |
Hill, AD; Ryan, ER; Skehan, SJ | 1 |
Jacobs, M; Mantil, J; Rehani, B; Strohmeyer, P | 1 |
Alvarez Pérez, RM; Borrego Dorado, I; López Martín, J; Vázquez Albertino, R | 1 |
Ak, I; Gülbas, Z | 1 |
Nieweg, O; Valdés Olmos, R | 1 |
Aschoff, P; Bares, R; Brechtel, K; Claussen, CD; Eigentler, TK; Eschmann, SM; Garbe, C; Pfannenberg, C; Plathow, C; Schanz, S; Schlemmer, HP; Vonthein, R | 1 |
Dadras, SS; Leavitt, M; McDougall, IR; Niederkohr, RD | 1 |
Dummer, R; Hany, TF; Skalsky, J; Steinert, HC; Strobel, K | 1 |
Bhure, U; Hany, TF; Pestalozzi, BC; Schmitt, AM; Strobel, K | 1 |
Coakley, FV; Falk, MS; Franc, B; Hawkins, RA; Kashani-Sabet, M; Truitt, AK | 1 |
Borella, L; Cains, G; Lin, M; Lin, P; Watson, AM | 1 |
Cho, T; Formby, M; Lee, D; Wood, B | 1 |
Alavi, A; Basu, S | 1 |
Aupérin, A; Avril, MF; Boitier, F; Cavalcanti, A; Kolb, F; Leboulleux, S; Lumbroso, J; Mamelle, G; Masson, F; Maubec, E; Spatz, A; Suciu, V | 1 |
Gamie, SH; Niederkohr, RD | 1 |
Clayton, AC; Collins, DA; Karantanis, D; Subramaniam, RM | 1 |
Koskivuo, IO; Minn, HR; Seppänen, MP; Suominen, EA | 1 |
Dummer, R; Hany, TF; Husarik, DB; Pérez Lago, M; Steinert, HC; Strobel, K | 1 |
Niederkohr, RD; Quon, A; Rosenberg, J; Shabo, G | 1 |
Bhure, U; Dummer, R; Hany, TF; Joller-Jemelka, H; Kalff, V; Pérez Lago, M; Seifert, B; Skalsky, J; Steinert, HC; Strobel, K | 1 |
Reinhardt, MJ | 1 |
Acland, K; Constantinidou, A; Harries, M; Healy, C; Hofman, MS; O'Doherty, M | 1 |
Chung, HJ; Chung, KY; Jung, JY; Roh, MR | 1 |
Hall, NC; Martin, EW; Povoski, SP; Walker, MJ | 1 |
Akdemir, UO; Akyurek, N; Benekli, M; Berk, V; Coskun, U; Karabacak, NI; Yildiz, R | 1 |
Francis, IR; Gritters, LS; Wahl, RL; Zasadny, KR | 1 |
Ali, A; Alibazoglu, H; Fordham, E; LaMonica, G; Patel, PM | 1 |
Hoekstra, HJ; Kole, AC; Koops, HS; Nieweg, OE; Pruim, J; Roodenburg, JL; Vaalburg, W; Vermey, A | 1 |
Hustinx, R; Paquet, P; Piérard, GE; Rigo, P | 1 |
Johnson, T; Macfarlane, DJ; Sondak, V; Wahl, RL | 1 |
Easton, EJ; Greene, FL; Holder, WD; White, RL; Zuger, JH | 1 |
Carreras, JL; Gorospe, E; Maldonado, A; Montz, R; Nieto, C; Ortega, F; Pérez-Castejón, MJ; Ruiz, JA | 1 |
Glass, EC; Gupta, RK; Hsueh, EC; Morton, DL; Qi, K; Yee, R | 1 |
Bicik, I; Buck, A; Huch, RA; Steinert, HC; Trachsel, C; Voellmy, DR; von Schulthess, GK | 1 |
Alavi, A; Bénard, F; Fraker, D; Jimenez-Hoyuela, J; Lampreave, JL | 1 |
Borgstein, PJ; Hoekstra, OS; Meijer, S; Mijnhout, GS; Pijpers, R; Teule, GJ | 1 |
Coleman, JJ; Davidson, D; Hayes, JT; Hutchins, G; Love, C; Saxman, S; Schauwecker, D; Wagner, JD | 1 |
Bicik, I; Engel, H; Krestin, GP; von Schulthess, GK; Wiesner, W | 1 |
Akhurst, T; Berlangieri, SU; Feigen, M; Hannah, A; McKay, WJ; Quong, G; Scott, AM; Zalcberg, J; Zimet, A | 1 |
Andersson, AP; Dahlstrøm, K; Drzewiecki, KT; Eigtved, A; Friberg, L; Holm, S; Højgaard, L; Jensen, M; Rabøl, A; Sørensen, SS | 1 |
Acland, KM; O'Doherty, MJ; Russell-Jones, R | 1 |
Chisin, R; Freedman, N; Gimon, Z; Klein, M; Lotem, M; Marciano, R; Moshe, S | 1 |
Coleman, E; Fisher, S; Hata, A; Keogan, M; Kherani, A; Nicholson, E; Onaitis, M; Seigler, HF; Tyler, DS | 1 |
Czernin, J; Essner, R; Gambhir, SS; Jahan, SA; Park, K; Patel, A; Phelps, ME; Schwimmer, J; Shepherd, JE | 1 |
Belli, F; Bombardieri, E; Cascinelli, N; Crippa, F; Gallino, F; Greco, M; Leutner, M; Pilotti, S | 1 |
Dietlein, M; Gossmann, A; Groth, W; Krug, B; Lackner, K; Psaras, T; Scheidhauer, K; Schicha, H; Stützer, H | 1 |
Ak, I; Pauwels, EK; Stokkel, MP | 1 |
Devillé, WL; Hoekstra, OS; Mijnhout, GS; Teule, GJ; van Tulder, MW | 1 |
Acland, KM; Calonje, E; Healy, C; Higgins, E; Nunan, T; O'Doherty, M; Page, C; Russell-Jones, R | 1 |
Hoegerle, S; Joe, A; Moser, E | 1 |
Buck, A; Dankerl, A; Reske, SN; Schirrmeister, H | 1 |
Binns, DS; Greer, B; Hicks, RJ; Hogg, A; Kalff, V; Ware, RE | 1 |
Nabi, HA; Zubeldia, JM | 1 |
Hill, AD; O'Higgins, NJ; Prichard, RS; Skehan, SJ | 1 |
Adèr, HJ; Boers, M; Comans, EF; De Gast, GC; Hoekstra, OS; Mijnhout, GS; Raijmakers, P; Teule, GJ | 1 |
Aigner, RM; Nicoletti, R; Schwarz, T; Wolf, G | 1 |
Bégány, A; Esik, O; Galuska, L; Gilde, K; Hunyadi, J; Ocsai, H; Szakáll, S; Török, L; Trón, L | 1 |
37 review(s) available for fluorodeoxyglucose f18 and Skin Neoplasms
Article | Year |
---|---|
GLUT1, GLUT3 Expression and 18FDG-PET/CT in Human Malignant Melanoma: What Relationship Exists? New Insights and Perspectives.
Topics: Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 3; Humans; Melanoma; Positron Emission Tomography Computed Tomography; Publications; Skin Neoplasms | 2021 |
PET/CT variants and pitfalls in malignant melanoma.
Topics: COVID-19; Fluorodeoxyglucose F18; Humans; Melanoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; SARS-CoV-2; Skin Neoplasms | 2022 |
Diagnostic Test Accuracy of 18 F-FDG PET or PET/CT in Merkel Cell Carcinoma.
Topics: Carcinoma, Merkel Cell; Diagnostic Tests, Routine; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms | 2022 |
Topics: Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Humans; Immunotherapy; Melanoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin Neoplasms; Treatment Outcome | 2020 |
Clinical Value of PET/CT in Staging Melanoma and Potential New Radiotracers.
Topics: Animals; Fluorodeoxyglucose F18; Humans; Melanoma; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin Neoplasms; Treatment Outcome | 2020 |
Malignant Cutaneous Melanoma: Updates in PET Imaging.
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Melanoma; Melanoma, Cutaneous Malignant; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed | 2020 |
The Role of PET/CT in the Era of Immune Checkpoint Inhibitors: State of Art.
Topics: Animals; Antineoplastic Agents, Immunological; Fluorodeoxyglucose F18; Humans; Melanoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin Neoplasms | 2020 |
CT, MRI and PET/CT features of abdominal manifestations of cutaneous melanoma: a review of current concepts in the era of tumor-specific therapies.
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Melanoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed | 2021 |
Precision Nuclear Medicine: The Evolving Role of PET in Melanoma.
Topics: Fluorodeoxyglucose F18; Humans; Melanoma; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Precision Medicine; Radiopharmaceuticals; Skin Neoplasms | 2021 |
Acute toxoplasmosis mimicking melanoma metastases: review of conditions causing false-positive results on (18)F-FDG PET/CT.
Topics: Antibodies, Protozoan; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Immunoglobulin G; Immunoglobulin M; Lymphadenitis; Male; Melanoma; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Skin Neoplasms; Tomography, X-Ray Computed; Toxoplasmosis | 2012 |
Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in patients with Merkel cell carcinoma: a systematic review and meta-analysis.
Topics: Carcinoma, Merkel Cell; Fluorodeoxyglucose F18; Humans; Likelihood Functions; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Skin Neoplasms; Tomography, X-Ray Computed | 2013 |
Positron emission tomography/computed tomography in melanoma.
Topics: Biomarkers, Tumor; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Melanoma; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2013 |
Value of positron emission tomography scan in stage III cutaneous melanoma: a systematic review and meta-analysis.
Topics: Fluorodeoxyglucose F18; Humans; Melanoma; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Skin Neoplasms | 2014 |
Malignant skin and subcutaneous neoplasms in adults: multimodality imaging with CT, MRI, and 18F-FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Soft Tissue Neoplasms; Subcutaneous Tissue; Tomography, X-Ray Computed | 2014 |
PET/Computed Tomography and Patient Outcomes in Melanoma.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Outcome Assessment; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Skin Neoplasms; Survival Analysis; Tomography, X-Ray Computed | 2015 |
The role of 18F-FDG PET and PET/CT in the evaluation of primary cutaneous lymphoma.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Skin Neoplasms | 2017 |
Mycosis fungoides staged by 18F-flurodeoxyglucose positron emission tomography/computed tomography: Case report and review of literature.
Topics: Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Mycosis Fungoides; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin Neoplasms | 2016 |
Imaging in cutaneous melanoma.
Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Melanoma; Positron-Emission Tomography; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Skin Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2008 |
Role of PET in the initial staging of cutaneous malignant melanoma: systematic review.
Topics: Fluorodeoxyglucose F18; Humans; Melanoma; Neoplasm Metastasis; Neoplasm Staging; Odds Ratio; Positron-Emission Tomography; Sensitivity and Specificity; Skin Neoplasms | 2008 |
Metastatic malignant melanoma.
Topics: Antineoplastic Agents; Chemotherapy, Adjuvant; Diagnosis, Differential; Evidence-Based Medicine; Fluorodeoxyglucose F18; Humans; Immunotherapy; Magnetic Resonance Imaging; Melanoma; Positron-Emission Tomography; Prognosis; Radiotherapy, Adjuvant; Skin Neoplasms; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Meta-analysis of the performance of (18)F-FDG PET in cutaneous melanoma.
Topics: Fluorodeoxyglucose F18; Humans; Incidence; Melanoma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms | 2010 |
Extranodal manifestations of lymphoma on [¹⁸F]FDG-PET/CT: a pictorial essay.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed | 2011 |
F-18-fluoro-2-deoxyglucose positron emission tomography (PET) and PET/computed tomography imaging in primary staging of patients with malignant melanoma: a systematic review.
Topics: Fluorodeoxyglucose F18; Humans; Melanoma; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Skin Neoplasms; Tomography, X-Ray Computed | 2012 |
New diagnostic techniques in staging in the surgical treatment of cutaneous malignant melanoma.
Topics: Biomarkers, Tumor; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Melanoma; Neoplasm Staging; Radiopharmaceuticals; Reverse Transcriptase Polymerase Chain Reaction; Sentinel Lymph Node Biopsy; Skin Neoplasms; Tomography, Emission-Computed | 2002 |
[Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in skin and ocular melanoma].
Topics: Eye Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Melanoma; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed | 2003 |
Positron emission tomography for basal cell carcinoma of the head and neck.
Topics: Aged; Aged, 80 and over; Carcinoma, Basal Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Skin Neoplasms; Tomography, Emission-Computed | 2003 |
Update on diagnostic imaging for melanoma.
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Melanoma; Neoplasm Staging; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Skin Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Clinical use of positron emission tomography in the management of cutaneous melanoma.
Topics: Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphatic Metastasis; Melanoma; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Skin Neoplasms; Treatment Outcome | 2004 |
Fluorodeoxyglucose-PET in the management of malignant melanoma.
Topics: Fluorodeoxyglucose F18; Humans; Melanoma; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms | 2005 |
Clinical applications of fluorodeoxyglucose--positron emission tomography in the management of malignant melanoma.
Topics: Fluorodeoxyglucose F18; Humans; Melanoma; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms | 2005 |
Malignant melanoma: PET/CT as a staging procedure.
Topics: Fluorodeoxyglucose F18; Humans; Melanoma; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2006 |
Cutaneous melanoma.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Tomography, X-Ray Computed | 2008 |
A review of the literature for whole-body FDG PET in the management of patients with melanoma.
Topics: Confidence Intervals; Cost-Benefit Analysis; Decision Support Techniques; False Negative Reactions; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Melanoma; Neoplasm Recurrence, Local; Neoplasm Staging; Peer Review, Research; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Technology Assessment, Biomedical; Tomography, Emission-Computed; Whole-Body Irradiation | 2000 |
Positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose in oncology. Part II. The clinical value in detecting and staging primary tumours.
Topics: Breast Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Melanoma; Neoplasm Staging; Neoplasms; Ovarian Neoplasms; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed | 2000 |
Systematic review of the diagnostic accuracy of (18)F-fluorodeoxyglucose positron emission tomography in melanoma patients.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Melanoma; Odds Ratio; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 2001 |
Clinical applications of (18)F-FDG in oncology.
Topics: Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Melanoma; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed | 2002 |
Positron emission tomography for staging and management of malignant melanoma.
Topics: Fluorodeoxyglucose F18; Humans; Melanoma; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Skin Neoplasms; Tomography, Emission-Computed | 2002 |
14 trial(s) available for fluorodeoxyglucose f18 and Skin Neoplasms
Article | Year |
---|---|
The role of interim
Topics: Female; Fluorodeoxyglucose F18; Humans; Ipilimumab; Male; Melanoma; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Treatment Outcome | 2018 |
Evaluation of positron emission tomography imaging to detect lymph node metastases in patients with high-risk cutaneous squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Skin Neoplasms | 2016 |
Whole body PET/CT in the follow-up of asymptomatic patients with stage IIB-IIIB cutaneous melanoma
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Skin Neoplasms; Young Adult | 2016 |
Diagnostic accuracy of contrast-enhanced FDG-PET/CT in primary staging of cutaneous malignant melanoma.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity; Skin Neoplasms; Time Factors; Tomography, X-Ray Computed | 2009 |
Verification of musculoskeletal FDG-PET-CT findings performed for melanoma staging.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Melanoma; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Skin Neoplasms; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2010 |
Cost-effectiveness of adding FDG-PET or CT to the diagnostic work-up of patients with stage III melanoma.
Topics: Adult; Aged; Aged, 80 and over; Cost-Benefit Analysis; Female; Fluorodeoxyglucose F18; Hospital Costs; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Multidetector Computed Tomography; Neoplasm Staging; Netherlands; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms | 2012 |
Marked, homogeneous, and early [18F]fluorodeoxyglucose-positron emission tomography responses to vemurafenib in BRAF-mutant advanced melanoma.
Topics: Adult; Aged; Aged, 80 and over; Australia; Biomarkers, Tumor; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Early Diagnosis; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Indoles; Male; Maximum Tolerated Dose; Melanoma; Middle Aged; Monitoring, Physiologic; Mutation; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Statistics, Nonparametric; Sulfonamides; Survival Analysis; Treatment Outcome; Vemurafenib | 2012 |
18-FDG PET/CT assessment of basal cell carcinoma with vismodegib.
Topics: Adult; Aged; Aged, 80 and over; Anilides; Antineoplastic Agents; Bone Neoplasms; Carcinoma, Basal Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Muscle Neoplasms; Positron-Emission Tomography; Pyridines; Skin Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
In-111 DTPA-octreotide scintigraphy for disease detection in metastatic thyroid cancer: comparison with F-18 FDG positron emission tomography and extensive conventional radiographic imaging.
Topics: Bone Neoplasms; Carcinoma; Cohort Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Octreotide; Pentetic Acid; Pleural Neoplasms; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Thyroid Neoplasms; Tomography, Emission-Computed | 2003 |
Utility of preoperative [(18)]f fluorodeoxyglucose-positron emission tomography scanning in high-risk melanoma patients.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 2006 |
Interpretation, accuracy and management implications of FDG PET/CT in cutaneous malignant melanoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Assessing response to chemotherapy in metastatic melanoma with FDG PET: Early experience.
Topics: Adult; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Pilot Projects; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Skin Neoplasms; Treatment Outcome | 2007 |
Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy.
Topics: Adult; Aged; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed | 1999 |
Reproducibility and clinical value of 18F-fluorodeoxyglucose positron emission tomography in recurrent melanoma.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Observer Variation; Patient Care; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms; Statistics as Topic; Surveys and Questionnaires; Tomography, Emission-Computed; Whole-Body Counting | 2002 |
301 other study(ies) available for fluorodeoxyglucose f18 and Skin Neoplasms
Article | Year |
---|---|
Synchronous Recurrence of Metachronous Lung Cancer and Hodgkin Lymphoma Within an Axillary Lymph Node Isolated on 18F-FDG PET/CT.
Topics: Adult; Aged, 80 and over; Axilla; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lung; Lung Neoplasms; Lymph Nodes; Male; Melanoma; Positron Emission Tomography Computed Tomography; Skin Neoplasms; Thorax | 2022 |
Impressive Rapid Complete Response on FDG PET/CT to BRAF Inhibitors in a Metastatic Melanoma With Massive Tumor Burden.
Topics: Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Melanoma; Oximes; Positron Emission Tomography Computed Tomography; Proto-Oncogene Proteins B-raf; Pyridones; Pyrimidinones; Skin Neoplasms; Tumor Burden | 2022 |
[A case of metastatic melanoma in the gallbladder].
Topics: Aged; Fluorodeoxyglucose F18; Gallbladder; Humans; Magnetic Resonance Imaging; Male; Melanoma; Skin Neoplasms | 2021 |
FDG-PET/CT imaging for evaluating durable responses to immune check point inhibitors in patients with advanced cutaneous squamous cell carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Immunological; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Immune Checkpoint Inhibitors; Immunotherapy; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms; Treatment Outcome | 2021 |
Mosaic pattern of skin granuloma annulare on [18F]FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Granuloma; Granuloma Annulare; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms | 2022 |
Topics: Aged; Aged, 80 and over; Asymptomatic Diseases; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms | 2022 |
The diagnostic accuracy and clinical impact of FDG-PET/CT follow-up for patients on adjuvant immunotherapy for high-risk malignant melanoma.
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunotherapy; Melanoma; Melanoma, Cutaneous Malignant; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Skin Neoplasms | 2022 |
[
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Melanoma; Melanoma, Cutaneous Malignant; Positron Emission Tomography Computed Tomography; Quinolines; Skin Neoplasms | 2022 |
Total Variation Constrained Graph Manifold Learning Strategy for Cerenkov Luminescence Tomography.
Topics: Algorithms; Animals; Computer Simulation; Fluorodeoxyglucose F18; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Liver Neoplasms, Experimental; Luminescent Measurements; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, Optical; Urinary Bladder | 2022 |
Basosquamous Basal Cell Carcinoma with Bone Marrow Metastasis.
Topics: Bone Marrow Neoplasms; Bone Neoplasms; Carcinoma, Basal Cell; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Skin Neoplasms | 2022 |
18F-FDG PET/CT During Neoadjuvant Targeted Therapy in Prior Unresectable Stage III Melanoma Patients: Can (Early) Metabolic Imaging Predict Histopathologic Response or Recurrence?
Topics: Fluorodeoxyglucose F18; Humans; Melanoma; Melanoma, Cutaneous Malignant; Mitogen-Activated Protein Kinase Kinases; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Radiopharmaceuticals; Skin Neoplasms | 2022 |
Comparison of 68Ga-FAPI and 18F-FDG PET/CT in Dermatofibrosarcoma Protuberans.
Topics: Dermatofibrosarcoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Quinolines; Skin Neoplasms | 2022 |
A Rare Widespread Cutaneous Langerhans Cell Histiocytosis Manifested on 18 F-FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Histiocytosis, Langerhans-Cell; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Skin Neoplasms | 2022 |
Increased 68 Ga-FAPI Uptake in Dermatofibrosarcoma Protuberans.
Topics: Biological Transport; Dermatofibrosarcoma; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Skin Neoplasms | 2022 |
Brain metabolic changes in patients with disseminated malignant melanoma under immunotherapy.
Topics: Brain; Fluorodeoxyglucose F18; Humans; Immunotherapy; Melanoma; Melanoma, Cutaneous Malignant; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms | 2022 |
Earlier Recurrence Detection Using Routine FDG PET-CT Scans in Surveillance of Stage IIB to IIID Melanoma: A National Cohort Study of 1480 Patients.
Topics: Cohort Studies; Fluorodeoxyglucose F18; Humans; Melanoma; Melanoma, Cutaneous Malignant; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms | 2023 |
18F-FDG PET-CT in Cutaneous Metastases in Breast Carcinoma: An unusual presentation.
Topics: Breast Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Skin Neoplasms | 2023 |
The influence of metastatic patterns and tumor load on therapeutic efficacy of immunotherapy in patients with metastatic melanoma as determined by quantitative PET-parameters using [ 18 F]-fluorodeoxyglucose PET/computed tomography.
Topics: Fluorodeoxyglucose F18; Humans; Immunotherapy; Lymphatic Metastasis; Melanoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms; Tumor Burden | 2023 |
Internal Thoracic Vein Tumor Thrombus From Sternal Melanoma Metastasis on 18 F-FDG PET/CT.
Topics: Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Melanoma; Neoplasm Metastasis; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Skin Neoplasms; Sternum; Thrombosis | 2023 |
[
Topics: Fluorodeoxyglucose F18; Humans; Lymphangiosarcoma; Lymphedema; Positron Emission Tomography Computed Tomography; Skin Neoplasms | 2023 |
Malignant Melanoma of the External Auditory Canal on 68 Ga-FAPI PET/CT.
Topics: Ear Canal; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Positron Emission Tomography Computed Tomography; Skin Neoplasms | 2023 |
A rare involvement in skin cancer: Merkel cell carcinoma with bone marrow infiltration in a kidney transplant recipient.
Topics: Bone Marrow; Carcinoma, Merkel Cell; Fluorodeoxyglucose F18; Humans; Kidney Transplantation; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Skin Neoplasms | 2023 |
Transformed Giant Congenital Melanocytic Nevus on 18 F-FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nevus, Pigmented; Positron Emission Tomography Computed Tomography; Skin Neoplasms | 2023 |
Diagnostic value of 18 F-fluoro-2-deoxyglucose positron emission tomography/computed tomography imaging in acral melanoma-predominant Asian patients.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Melanoma; Melanoma, Cutaneous Malignant; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2023 |
The utility of PET-CT in the staging and management of advanced and recurrent malignant melanoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms; Young Adult | 2019 |
The Utility of 18F-fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography in Cutaneous B-Cell Lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Skin; Skin Neoplasms; Young Adult | 2019 |
Restaging [
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Proportional Hazards Models; Retrospective Studies; Skin Neoplasms; Treatment Outcome | 2020 |
Clinical and Prognostic Value of
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Skin Neoplasms | 2020 |
Gastrointestinal: Anterior mediastinal colonic interposition on F-18 FDG PET/CT imaging.
Topics: Carcinoma, Squamous Cell; Colon; Digestive System Surgical Procedures; Epidermolysis Bullosa Dystrophica; Esophageal Diseases; Esophagectomy; Fluorodeoxyglucose F18; Humans; Male; Mediastinum; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin Neoplasms | 2020 |
Nivolumab-Induced Subcutaneous Fat Necrosis: Another FDG-Avid Immune-Related Adverse Event.
Topics: Fat Necrosis; Female; Fluorodeoxyglucose F18; Humans; Image-Guided Biopsy; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Nivolumab; Positron Emission Tomography Computed Tomography; Skin Neoplasms; Subcutaneous Fat | 2020 |
18F-FDG PET/CT Findings in Metastatic Pilomatrix Carcinoma.
Topics: Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Hair Follicle; Humans; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin Neoplasms | 2020 |
Pedunculated aneurysmal fibrous histiocytoma with increased
Topics: Aged; Female; Fluorodeoxyglucose F18; Histiocytoma, Benign Fibrous; Humans; Positron Emission Tomography Computed Tomography; Skin; Skin Neoplasms | 2020 |
The Clinical Significance of Incidental Parotid Uptake in a PET/CT Study: A Diagnostic Algorithm.
Topics: Adenolymphoma; Biopsy, Fine-Needle; Databases, Factual; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Melanoma; Parotid Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Risk Assessment; Skin Neoplasms | 2019 |
Prognostic 18F-FDG PET biomarkers in metastatic mucosal and cutaneous melanoma treated with immune checkpoint inhibitors targeting PD-1 and CTLA-4.
Topics: CTLA-4 Antigen; Fluorodeoxyglucose F18; Humans; Immune Checkpoint Inhibitors; Melanoma; Positron Emission Tomography Computed Tomography; Prognosis; Programmed Cell Death 1 Receptor; Retrospective Studies; Skin Neoplasms; Tumor Burden | 2020 |
18FDG PET/CT in Primary Cutaneous Diffuse Large B-Cell Lymphoma Leg Type.
Topics: Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Rituximab; Skin Neoplasms; Treatment Outcome | 2020 |
Metastatic melanoma: can FDG-PET predict success of anti-PD-1 therapy and help determine when it can be discontinued?
Topics: CTLA-4 Antigen; Fluorodeoxyglucose F18; Humans; Immune Checkpoint Inhibitors; Melanoma; Positron-Emission Tomography; Prognosis; Programmed Cell Death 1 Receptor; Skin Neoplasms | 2020 |
The role of FDG-PET-CT is limited in initial staging of nodal metastasis for thin cutaneous melanoma.
Topics: Biopsy; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Skin Neoplasms | 2021 |
Widespread Skin Infiltration of Leukemia Cutis on 18F-FDG PET/CT.
Topics: Aged; Biopsy; Fluorodeoxyglucose F18; Humans; Leukemia; Male; Positron Emission Tomography Computed Tomography; Skin Neoplasms | 2020 |
Cutaneous Metastases from Testicular Diffuse Large B-cell Malignant Lymphoma and Bowen Disease: 18F-FDG PET-CT Findings.
Topics: Bowen's Disease; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Radiopharmaceuticals; Skin Neoplasms; Testicular Neoplasms | 2020 |
A Rare Case of Solitary Pituitary Metastasis From Spitzoid Melanoma Detected by FDG PET/CT.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Pituitary Neoplasms; Positron Emission Tomography Computed Tomography; Skin Neoplasms | 2020 |
Multiple Cutaneous Leiomyomas Showing Increased FDG Uptake.
Topics: Biological Transport; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Leiomyomatosis; Male; Neoplastic Syndromes, Hereditary; Skin Neoplasms; Uterine Neoplasms | 2020 |
Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in Large Arteries.
Topics: Aged; Aged, 80 and over; Aorta; Arteritis; CTLA-4 Antigen; Female; Fluorodeoxyglucose F18; Humans; Iliac Artery; Immune Checkpoint Inhibitors; Immunity, Innate; Male; Melanoma; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Programmed Cell Death 1 Receptor; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Skin Neoplasms | 2020 |
Thyroid Metastasis From Cutaneous Melanoma on an 18F-FDG PET/CT Study.
Topics: Fluorodeoxyglucose F18; Humans; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Positron Emission Tomography Computed Tomography; Skin Neoplasms; Thyroid Neoplasms | 2020 |
BRAF inhibitor-induced panniculitis in patients treated for stage IV metastatic melanoma: a case series.
Topics: Fluorodeoxyglucose F18; Humans; Melanoma; Mutation; Panniculitis; Positron Emission Tomography Computed Tomography; Proto-Oncogene Proteins B-raf; Skin Neoplasms | 2021 |
Mediastinal FDG-positive lymph nodes simulating melanoma progression: drug-induced sarcoidosis like/lymphadenopathy related to ipilimumab.
Topics: Adult; Back; Biopsy; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Immune Checkpoint Inhibitors; Ipilimumab; Lymph Nodes; Lymphadenopathy; Mediastinum; Melanoma; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin Neoplasms | 2021 |
Primary Cutaneous Natural Killer/T-Cell Lymphoma: A Posttransplant Lymphoproliferative Disorder Demonstrated by 18F-FDG PET/CT.
Topics: Bone Marrow Transplantation; Fluorodeoxyglucose F18; Humans; Killer Cells, Natural; Lymphoma, T-Cell, Cutaneous; Male; Positron Emission Tomography Computed Tomography; Skin Neoplasms; Young Adult | 2021 |
18F-FDG PET/CT Monitoring of Response to Programmed Death Protein 1 Blockade in Metastatic Basal Cell Carcinoma.
Topics: Aged; Antibodies, Monoclonal, Humanized; Carcinoma, Basal Cell; Female; Fluorodeoxyglucose F18; Hedgehog Proteins; Humans; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Programmed Cell Death 1 Receptor; Signal Transduction; Skin Neoplasms; Treatment Outcome | 2021 |
Imaging findings of cutaneous angiosarcoma of the scalp: Comparison with cutaneous squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Magnetic Resonance Imaging; Retrospective Studies; Scalp; Skin Neoplasms | 2021 |
PET/CT in malignant melanoma: a two-tiered healthcare system? Updated healthcare situation regarding initial staging of malignant melanoma with PET/CT.
Topics: Delivery of Health Care; Fluorodeoxyglucose F18; Humans; Melanoma; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Skin Neoplasms; Tomography, X-Ray Computed | 2021 |
Difficulties encountered in the diagnosis of primary esophageal malignant melanoma by 18F-fluorodeoxyglucose positron emission tomography/computed tomography: a case report.
Topics: Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Melanoma; Middle Aged; Positron Emission Tomography Computed Tomography; Skin Neoplasms | 2021 |
Surgical Resection After Talimogene Laherparepvec for Melanoma: Persistent Fuorodeoxyglucose Avidity on Positron Emission Tomography Despite No Viable Disease.
Topics: Adult; Aged; Antineoplastic Agents, Immunological; Biological Products; Combined Modality Therapy; Fluorodeoxyglucose F18; Herpesvirus 1, Human; Humans; Injections, Intralesional; Male; Melanoma; Middle Aged; Minnesota; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms; Ultrasonography | 2021 |
False positive FDG uptake in melanoma patients treated with talimogene laherparepvec (T-VEC).
Topics: Aged; Antineoplastic Agents, Immunological; Biological Products; Cohort Studies; False Positive Reactions; Female; Fluorodeoxyglucose F18; Herpesvirus 1, Human; Humans; Lymph Nodes; Male; Melanoma; Melanoma, Cutaneous Malignant; Oncolytic Virotherapy; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms | 2021 |
Imaging findings of melanoma metastasis in the gallbladder.
Topics: Adult; Fluorodeoxyglucose F18; Gallbladder; Humans; Lymph Nodes; Male; Melanoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms | 2022 |
Targeting personalized medicine in a non-Hodgkin lymphoma patient with 18F-FDG and 18F-choline PET/CT.
Topics: Choline; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin Neoplasms; Sternum | 2017 |
Distal appendicular skeletal involvement of diffuse large B-cell lymphoma on technetium-99m methylenediphosphonate bone scintigraphy and
Topics: Aged; Bone Neoplasms; Diphosphonates; Fluorodeoxyglucose F18; Gingivitis; Humans; Immunohistochemistry; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Maxilla; Organotechnetium Compounds; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy; Skin Neoplasms; Testicular Neoplasms; Tooth Extraction; Treatment Outcome; Whole Body Imaging | 2017 |
Primary Cutaneous Angiosarcoma Mimicking Metastasis on 18F-FDG PET/CT in Woman With Cervix Cancer.
Topics: Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Skin Neoplasms; Uterine Cervical Neoplasms | 2017 |
Topics: Adolescent; Adult; Aged; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large-Cell, Anaplastic; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed; Young Adult | 2017 |
Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome Combined With Adrenocortical Carcinoma on 18F-FDG PET/CT.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Leiomyomatosis; Neoplastic Syndromes, Hereditary; Positron Emission Tomography Computed Tomography; Skin Neoplasms; Uterine Neoplasms; Young Adult | 2017 |
The diagnostic utility of Merkel cell polyomavirus immunohistochemistry in a fine needle aspirate of metastatic Merkel cell carcinoma of unknown primary to the pancreas.
Topics: Adult; Antigens, Polyomavirus Transforming; Carcinoma, Merkel Cell; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Fluorodeoxyglucose F18; Humans; Male; Merkel cell polyomavirus; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms | 2018 |
Clinical relevance of 18F-FDG PET/CT lower-limb imaging in patients with malignant cutaneous melanoma.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lower Extremity; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Skin Neoplasms; Thigh | 2017 |
Merkel cell carcinoma cardiac metastasis causing cardiac tamponade.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Merkel Cell; Cardiac Tamponade; Cisplatin; Elbow; Etoposide; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Male; Middle Aged; Pericardiocentesis; Positron-Emission Tomography; Skin Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2017 |
Incidental detection of colorectal lesions by FDG PET/CT scans in melanoma patients.
Topics: Australia; Colonoscopy; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Melanoma; Middle Aged; Positron Emission Tomography Computed Tomography; Prevalence; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms; Survival Rate | 2017 |
Concomitant cutaneous squamous cell carcinoma and chronic lymphocytic leukemia in a patient: The utility of
Topics: Abdominal Pain; Aged; Biopsy; Biopsy, Fine-Needle; Carcinoma, Squamous Cell; Ear Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphatic Metastasis; Male; Neck Dissection; Neoplasms, Multiple Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin Neoplasms | 2018 |
Retrospective study on the correlation between 18-fluorodeoxyglucose uptake in positron emission tomography-computer tomography and tumour volume, cytological activity as assessed with Ki-67 and GLUT-1 staining in 10 cases of Merkel cell carcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma, Merkel Cell; Cell Proliferation; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Ki-67 Antigen; Male; Positron Emission Tomography Computed Tomography; Retrospective Studies; Skin Neoplasms; Tumor Burden | 2018 |
Prospective analysis of the utility of 18-FDG PET in Merkel cell carcinoma of the skin: A Trans Tasman Radiation Oncology Group Study, TROG 09:03.
Topics: Aged; Carcinoma, Merkel Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Survival Rate | 2018 |
BSREM Reconstruction for Improved Detection of In-Transit Metastases With Digital FDG-PET/CT in Patients With Malignant Melanoma.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Melanoma; Melanoma, Cutaneous Malignant; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin Neoplasms | 2018 |
18F-FDG PET/CT for Monitoring Response of Merkel Cell Carcinoma to the Novel Programmed Cell Death Ligand 1 Inhibitor Avelumab.
Topics: Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carcinoma, Merkel Cell; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin Neoplasms | 2018 |
Increased uptake on
Topics: Aged; Biopsy; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Neoplasm Invasiveness; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin; Skin Neoplasms | 2018 |
Rapidly growing pulmonary ground-glass nodule caused by metastatic melanoma lacking uptake on 18F-FDG PET-CT.
Topics: Adult; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Melanoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin Neoplasms | 2018 |
[The role of preoperative (18)F-FDG PET-CT in lymphatic metastasis diagnosis of cutaneous malignant melanoma on extremities and trunk].
Topics: Extremities; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Melanoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Skin Neoplasms; Torso | 2018 |
Considerations on 18FDG PET/CT and sentinel lymph node biopsy in AJCC stages I and II of melanoma.
Topics: Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2020 |
Unexpected positron emission tomography/computed tomography uptake in benign dermal naevus.
Topics: Aged; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Nevus; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Scalp; Skin Neoplasms | 2019 |
Pelvic lymph node dissection in metastatic melanoma to the groin should not be abandoned yet.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Groin; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms | 2018 |
Multiple Subcutaneous Nodules as Initial Presentation of Diffuse Large B-cell Non-Hodgkin Lymphoma (DLBCL) Detected by PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Skin Neoplasms | 2018 |
Innocent PET avidity in patient with metastatic melanoma.
Topics: Biological Transport; Diagnosis, Differential; Exercise; Fluorodeoxyglucose F18; Groin; Humans; Male; Melanoma; Middle Aged; Patient Education as Topic; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin Neoplasms | 2018 |
Osteoblastic bone response mimicking bone progression during treatment with pembrolizumab in advanced cutaneous melanoma.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Bone Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Melanoma; Middle Aged; Osteoblasts; Positron-Emission Tomography; Skin Neoplasms; Tomography, X-Ray Computed | 2018 |
Re: Prospective analysis of the utility of 18-FDG PET in Merkel cell carcinoma of the skin: A Trans Tasman Radiation Oncology Group Study, TROG 09:03 (Journal of Medical Imaging and Radiation Oncology 62 (2018) 412-419).
Topics: Carcinoma, Merkel Cell; Fluorodeoxyglucose F18; Humans; Prospective Studies; Skin; Skin Neoplasms | 2018 |
Hibernoma as an incidental finding in the 18F-FDG PET/CT of a patient with melanoma.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lipoma; Melanoma; Middle Aged; Positron Emission Tomography Computed Tomography; Skin Neoplasms | 2020 |
Small Primary Cutaneous γδT-Cell Lymphoma Lesions Successfully Treated With Pralatrexate.
Topics: Adult; Aminopterin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Cutaneous; Positron-Emission Tomography; Skin Neoplasms; Treatment Outcome | 2019 |
Monitoring response of advanced Merkel cell carcinoma to Avelumab with
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Carcinoma, Merkel Cell; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Skin Neoplasms; Treatment Outcome | 2019 |
Physiologic colonic fluorine-18-fluorodeoxyglucose uptake may predict response to immunotherapy in patients with metastatic melanoma.
Topics: Antineoplastic Agents, Immunological; Colon; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunotherapy; Ipilimumab; Melanoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Skin Neoplasms | 2019 |
A Nodular Lesion of the Foot Detected by 18F-FDG PET/CT in Mycosis Fungoides: A Plantar Wart.
Topics: Adult; Female; Fluorodeoxyglucose F18; Foot; Humans; Mycosis Fungoides; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin Neoplasms; Warts | 2019 |
Extensive bony metastases from facial metatypical basal cell carcinoma: a case report.
Topics: Adult; Carcinoma, Basal Cell; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin Neoplasms | 2019 |
The clinical value of imaging in primary cutaneous lymphomas: Role of high resolution ultrasound and PET-CT.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Skin; Skin Neoplasms; Ultrasonography; Young Adult | 2019 |
18F-FDG PET/CT longitudinal studies in patients with advanced metastatic melanoma for response evaluation of combination treatment with vemurafenib and ipilimumab.
Topics: Adult; Aged; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Humans; Ipilimumab; Longitudinal Studies; Male; Melanoma; Middle Aged; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Skin Neoplasms; Treatment Outcome; Vemurafenib | 2019 |
Rapidly Evolving Extensive Fluorodeoxyglucose-Positive Soft-Tissue Activity During Nivolumab Therapy.
Topics: Adult; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Humans; Ipilimumab; Melanoma; Nivolumab; Panniculitis; Positron Emission Tomography Computed Tomography; Skin Neoplasms | 2019 |
FDG-PET/CT for Spontaneous Regression of Metastatic Merkel Cell Carcinoma: Friend or Foe?
Topics: Aged, 80 and over; Carcinoma, Merkel Cell; Eyelids; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Parotid Neoplasms; Positron Emission Tomography Computed Tomography; Remission, Spontaneous; Skin Neoplasms | 2019 |
Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome-Associated Renal Cell Carcinoma Showing High FDG Uptake.
Topics: Adult; Carcinoma, Renal Cell; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Leiomyomatosis; Neoplastic Syndromes, Hereditary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin Neoplasms; Uterine Neoplasms | 2019 |
Cardiac Metastases in Melanoma.
Topics: Female; Fluorodeoxyglucose F18; Heart; Heart Neoplasms; Humans; Melanoma; Middle Aged; Positron-Emission Tomography; Skin Neoplasms | 2019 |
[
Topics: Antineoplastic Agents, Immunological; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Keratinocytes; Lung Neoplasms; Male; Melanoma; Middle Aged; Nivolumab; Positron Emission Tomography Computed Tomography; Prurigo; Radiopharmaceuticals; Skin Neoplasms | 2019 |
Profound MEK inhibitor response in a cutaneous melanoma harboring a GOLGA4-RAF1 fusion.
Topics: Aged; Alleles; Autoantigens; beta Catenin; Cyclin-Dependent Kinase Inhibitor p16; Extracellular Signal-Regulated MAP Kinases; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Male; MAP Kinase Kinase 1; Melanoma; Neoplasm Metastasis; Oncogene Proteins, Fusion; Positron-Emission Tomography; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-raf; Skin Neoplasms | 2019 |
Merkel cell carcinoma: an aggressive cutaneous carcinoma with rare metastasis to the thyroid gland.
Topics: Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; B7-H1 Antigen; Carcinoma, Merkel Cell; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Skin Neoplasms; Thyroid Gland; Thyroid Neoplasms | 2019 |
Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab.
Topics: Aged; Antineoplastic Agents, Immunological; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Nivolumab; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms; Survival Analysis; Thyroid Gland; Thyroiditis; Thyrotropin; Thyroxine; Triiodothyronine | 2019 |
Clinical value of 18F-FDG-PET/CT in staging cutaneous squamous cell carcinoma.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Skin Neoplasms | 2019 |
Metastatic Extramammary Paget Disease of the Perianal Region.
Topics: Aged; Fluorodeoxyglucose F18; Groin; Humans; Male; Neoplasm Metastasis; Paget Disease, Extramammary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin Neoplasms | 2019 |
Interstitial nephritis in immune checkpoint inhibitor therapy.
Topics: Aged; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Ipilimumab; Kidney; Melanoma; Nephritis, Interstitial; Positron Emission Tomography Computed Tomography; Skin Neoplasms; Treatment Outcome | 2019 |
18F-FDG PET/CT in Lymphomatoid Papulosis Mimicking Primary Cutaneous Anaplastic Large Cell Lymphoma.
Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Primary Cutaneous Anaplastic Large Cell; Lymphomatoid Papulosis; Positron Emission Tomography Computed Tomography; Skin Neoplasms | 2019 |
Prediction of response to immune checkpoint inhibitor therapy using 18F-FDG PET/CT in patients with melanoma.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Protocols; Female; Fluorodeoxyglucose F18; Humans; Ipilimumab; Male; Melanoma; Melanoma, Cutaneous Malignant; Neoplasm Staging; Nivolumab; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Skin Neoplasms; Tomography, X-Ray Computed | 2019 |
Comparison of (18)F-FDG PET/CT and (68)Ga-DOTATATE PET/CT imaging in metastasized Merkel cell carcinoma.
Topics: Aged, 80 and over; Carcinoma, Merkel Cell; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Metastasis; Organometallic Compounds; Positron-Emission Tomography; Skin Neoplasms; Tomography, X-Ray Computed | 2013 |
Extramedullary disease in patients with acute myeloid leukemia assessed by 18F-FDG PET.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Leukemia, Myeloid, Acute; Lymph Nodes; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Skin Neoplasms; Treatment Outcome | 2013 |
Periarticular FDG Uptake on PET/CT in malignant melanoma-metastatic or misleading?
Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Gout; Humans; Joints; Male; Melanoma; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed | 2013 |
Outcome of clinical stage III melanoma patients with FDG-PET and whole-body CT added to the diagnostic workup.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Skin Neoplasms; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2013 |
"Invisible" primary cutaneous diffuse large B-cell lymphoma, leg type, as a cause of fever of unknown origin.
Topics: Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Humans; Leg; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Multimodal Imaging; Radiographic Image Interpretation, Computer-Assisted; Radionuclide Imaging; Skin Neoplasms | 2013 |
18F-FDG PET provides high-impact and powerful prognostic stratification in the staging of Merkel cell carcinoma: a 15-year institutional experience.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Merkel Cell; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Skin Neoplasms; Survival Analysis; Treatment Failure | 2013 |
18F-fluorodeoxyglucose positron emission tomography-computed tomography imaging in the management of Merkel cell carcinoma: a single-institution retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Merkel Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms; Tomography, X-Ray Computed | 2013 |
Soft tissue metastases from differentiated thyroid cancer diagnosed by ¹⁸F FDG PET-CT.
Topics: Adenocarcinoma, Papillary; Adult; Biopsy, Fine-Needle; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Muscle Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Soft Tissue Neoplasms; Thyroid Neoplasms; Tomography, X-Ray Computed | 2013 |
Patient-derived tumor xenograft model to guide the use of BRAF inhibitors in metastatic melanoma.
Topics: Adult; Animals; Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Female; Fluorodeoxyglucose F18; Humans; Indoles; Melanoma; Mice, SCID; Multimodal Imaging; Mutation; Positron-Emission Tomography; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Radiopharmaceuticals; Skin Neoplasms; Sulfonamides; Time Factors; Tomography, X-Ray Computed; Tumor Burden; Vemurafenib; Xenograft Model Antitumor Assays | 2013 |
Reduced-intensity conditioning followed by cord blood transplantation in a patient with refractory folliculotropic mycosis fungoides.
Topics: Adult; Biopsy; Cord Blood Stem Cell Transplantation; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mycosis Fungoides; Neoplasm Staging; Positron-Emission Tomography; Skin; Skin Neoplasms; Tomography, X-Ray Computed; Transplantation Conditioning | 2013 |
No benefit in staging fluorodeoxyglucose-positron emission tomography in clinically node-negative head and neck cutaneous melanoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Melanoma; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms | 2014 |
18FDG-PET to assess recurrence and long term survival in patients with malignant melanoma.
Topics: Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Germany; Humans; Male; Melanoma; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; S100 Calcium Binding Protein beta Subunit; Sensitivity and Specificity; Skin Neoplasms; Survival Analysis; Survivors; Tomography, X-Ray Computed | 2013 |
Comparison of whole-body versus limited whole-body 18F-FDG PET/CT scan in malignant cutaneous melanoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Skin Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2013 |
A low molecular weight zinc2+-dipicolylamine-based probe detects apoptosis during tumour treatment better than an annexin V-based probe.
Topics: Amines; Angiogenesis Inhibitors; Animals; Annexin A5; Apoptosis; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Indoles; Mice; Mice, Nude; Molecular Probes; Molecular Weight; Neoplasms, Experimental; Organometallic Compounds; Picolinic Acids; Pyrroles; Skin Neoplasms; Sunitinib; Tumor Cells, Cultured; Zinc | 2014 |
The impact of (18)F-FDG-PET/CT on Merkel cell carcinoma management: a retrospective study of 66 scans from a single institution.
Topics: Aged; Aged, 80 and over; Carcinoma, Merkel Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Recurrence; Retrospective Studies; Skin Neoplasms; Tomography, X-Ray Computed | 2014 |
18F-FDG PET/CT uptake due to poly-L-lactic acid facial injections.
Topics: Aged; Diagnosis, Differential; Facial Dermatoses; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lactic Acid; Male; Multimodal Imaging; Polyesters; Polymers; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed | 2013 |
Complete pathologic response after neoadjuvant treatment with vemurafenib for malignant melanoma.
Topics: Administration, Oral; Adult; Biopsy, Needle; Dermatologic Surgical Procedures; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunohistochemistry; Indoles; Male; Melanoma; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Sentinel Lymph Node Biopsy; Skin Neoplasms; Sulfonamides; Treatment Outcome; Vemurafenib | 2014 |
Successful administration of ipilimumab to two kidney transplantation patients with metastatic melanoma.
Topics: Administration, Oral; Aged; Antibodies, Monoclonal; Antineoplastic Agents; Dacarbazine; Drug Administration Schedule; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Ipilimumab; Kidney Transplantation; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Mycophenolic Acid; Platinum Compounds; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Skin Neoplasms; Tacrolimus; Temozolomide; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Cutaneous lesions of a blastic plasmacytoid dendritic cell neoplasm.
Topics: Aged; Antigens, CD; Dendritic Cells; Fluorodeoxyglucose F18; Hematologic Neoplasms; Humans; Immunohistochemistry; Male; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms | 2014 |
Isolated nasal tip metastasis from esophageal squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Nose Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed | 2015 |
FDG PET in early stage cutaneous malignant melanoma.
Topics: Early Detection of Cancer; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Melanoma; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms | 2014 |
Activity of trametinib in K601E and L597Q BRAF mutation-positive metastatic melanoma.
Topics: Aged; Antineoplastic Agents; Biopsy; Extracellular Signal-Regulated MAP Kinases; Female; Fluorodeoxyglucose F18; Humans; Male; MAP Kinase Signaling System; Melanoma; Middle Aged; Mutation; Neoplasm Metastasis; Phosphorylation; Positron-Emission Tomography; Proto-Oncogene Proteins B-raf; Pyridones; Pyrimidinones; Retrospective Studies; Signal Transduction; Skin Neoplasms; Treatment Outcome | 2014 |
Anaplastic cutaneous lymphoma mimicking an infection.
Topics: Adolescent; Contrast Media; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoma, Large-Cell, Anaplastic; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Skin Diseases, Infectious; Skin Neoplasms; Tomography, X-Ray Computed | 2014 |
FDG-PET/CT scan in a skin metastasis from lung cancer.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Skin Neoplasms; Tomography, X-Ray Computed | 2014 |
Ultrahigh-resolution Cerenkov-light imaging system for positron radionuclides: potential applications and limitations.
Topics: Animals; Autoradiography; Brain; Fluorodeoxyglucose F18; Molecular Imaging; Phantoms, Imaging; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rats, Nude; Skin Neoplasms; Sodium Radioisotopes | 2014 |
FDG PET/CT in evaluation of unusual cutaneous manifestations of breast cancer.
Topics: Aged; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed | 2015 |
A 72-year-old woman with a persistent cough and abnormal chest X-ray.
Topics: Aged; Antinematodal Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lung Neoplasms; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Skin Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Staging studies for cutaneous melanoma in the United States: a population-based analysis.
Topics: Aged; Aged, 80 and over; Cohort Studies; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Magnetic Resonance Imaging; Male; Melanoma; Melanoma, Cutaneous Malignant; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; SEER Program; Skin Neoplasms; Tissue Distribution; Tomography, X-Ray Computed; United States | 2015 |
Late-onset paraplegia after complete response to two cycles of ipilimumab for metastatic melanoma.
Topics: Antibodies, Monoclonal; Antineoplastic Agents, Alkylating; Colitis; Dacarbazine; Fluorodeoxyglucose F18; Humans; Ipilimumab; Magnetic Resonance Imaging; Male; Melanoma; Middle Aged; Multimodal Imaging; Myelitis; Paraplegia; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Temozolomide; Tomography, X-Ray Computed | 2014 |
Hybrid neurofibroma/schwannoma in neurofibromatosis type I exhibiting high FDG uptake in PET imaging.
Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurilemmoma; Neurofibromatosis 1; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms | 2015 |
Extensive invasive extramammary Paget disease evaluated by F-18 FDG PET/CT: a case report.
Topics: Adenocarcinoma; Fatal Outcome; Fluorodeoxyglucose F18; Groin; Hip; Humans; Male; Middle Aged; Neoplasm Metastasis; Paget Disease, Extramammary; Penis; Positron-Emission Tomography; Radiotherapy; Scrotum; Skin Neoplasms; Thigh; Tomography, X-Ray Computed | 2015 |
Bacillus Calmette-Guerin injections for melanoma immunotherapy: potential for a false-positive PET/CT.
Topics: Aged, 80 and over; BCG Vaccine; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy; Melanoma; Melanoma, Cutaneous Malignant; Multimodal Imaging; Radionuclide Imaging; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed | 2015 |
(18)FDG PET/CT appearance in primary cutaneous diffuse large B-cell lymphoma, leg type.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Leg; Lymphoma, Large B-Cell, Diffuse; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed | 2015 |
Diagnostic accuracy of (18)F-FDG-PET/CT in early and late stages of high-risk cutaneous malignant melanoma.
Topics: Adult; Aged; Aged, 80 and over; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Skin Neoplasms; Tomography, X-Ray Computed; Young Adult | 2015 |
Untreated Hodgkin Lymphoma With Skin Infiltration and Satellite Skin Nodule in a 15-Year-Old Female Adolescent.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Hodgkin Disease; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed; Vinblastine | 2015 |
Subcutaneous and muscular metastasis of the colorectal cancer on F-18 FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Muscle Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Retrospective Studies; Skin Neoplasms; Tomography, X-Ray Computed | 2015 |
Kikuchi-Fujimoto lymphadenitis imitating metastatic melanoma on positron emission tomography: a case report.
Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Histiocytic Necrotizing Lymphadenitis; Humans; Melanoma; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Tomography, X-Ray Computed | 2015 |
Preliminary discussion on the value of (18)F-FDG PET/CT in the diagnosis and early staging of non-mycosis fungoides/Sézary's syndrome cutaneous malignant lymphomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma; Male; Middle Aged; Multimodal Imaging; Mycosis Fungoides; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sezary Syndrome; Skin; Skin Neoplasms; Tomography, X-Ray Computed; Young Adult | 2015 |
Complete Remission in Systemic Skin Interdigitating Dendritic Cell Sarcoma after ABVD Chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Dacarbazine; Dendritic Cell Sarcoma, Interdigitating; Doxorubicin; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Immunophenotyping; Male; Middle Aged; Positron-Emission Tomography; Remission Induction; Skin; Skin Neoplasms; Vinblastine | 2015 |
15-Year Experience of 18F-FDG PET Imaging in Response Assessment and Restaging After Definitive Treatment of Merkel Cell Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Merkel Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Longitudinal Studies; Male; Middle Aged; Patient Outcome Assessment; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms; Survival Analysis; Survival Rate; Treatment Outcome | 2015 |
Influence of (18)F-FDG PET/CT on therapy management in patients with stage III/IV malignant melanoma.
Topics: Adult; Aged; Decision Making; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2016 |
Global Quantitative Techniques for Positron Emission Tomographic Assessment of Disease Activity in Cutaneous T-Cell Lymphoma and Response to Treatment.
Topics: Adult; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms | 2016 |
Lack of clinical impact of
Topics: Adult; Aged; Aged, 80 and over; Australia; Carcinoma, Merkel Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2017 |
Diagnostic value of 18F-FDG PET/CT for cutaneous extranodal natural killer/T-cell lymphoma, nasal type.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Skin Neoplasms; Young Adult | 2016 |
Multiparametric whole-body anatomic, functional, and metabolic imaging characteristics of peripheral lesions in patients with schwannomatosis.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Molecular Imaging; Multimodal Imaging; Neurilemmoma; Neurofibromatoses; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms; Whole Body Imaging | 2016 |
Prognostic Value of Volumetric Parameters Measured by Pretreatment 18F FDG PET/CT in Patients With Cutaneous Malignant Melanoma.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Multivariate Analysis; Positron Emission Tomography Computed Tomography; Probability; Recurrence; Retrospective Studies; ROC Curve; Skin Neoplasms; Tumor Burden | 2016 |
Metabolic assessment of Merkel cell carcinoma: the role of 18F-FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Merkel Cell; Computer Simulation; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Molecular Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms | 2016 |
Ulcerated giant pilomatricoma with appearance of cutaneous malignancy on positron emission tomography/computed tomography.
Topics: Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Hair Diseases; Humans; Leg; Male; Pilomatrixoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin; Skin Neoplasms; Skin Ulcer | 2017 |
[Cutaneous Merkel cell carcinoma: role of 18FDG PET-CT].
Topics: Adult; Carcinoma, Merkel Cell; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Skin Neoplasms | 2016 |
18F-FDG PET/CT and Melanoma: Value of Fourth and Subsequent Posttherapy Follow-up Scans for Patient Management.
Topics: Adult; Aftercare; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms | 2016 |
Zosteriform Secondary Cutaneous Diffuse Large B-Cell Lymphoma on FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Skin Neoplasms | 2016 |
Retrospective chart analysis of incidental findings detected by (18) F-fluorodeoxyglucose-PET/CT in patients with cutaneous malignant melanoma.
Topics: Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Melanoma; Positron Emission Tomography Computed Tomography; Retrospective Studies; Skin Neoplasms | 2016 |
Immune-mediated Disease in Ipilimumab Immunotherapy of Melanoma with FDG PET-CT.
Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Agents; Colitis; Female; Fluorodeoxyglucose F18; Humans; Hypophysitis; Immunotherapy; Ipilimumab; Male; Melanoma; Middle Aged; Multimodal Imaging; Pancreatitis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Skin Neoplasms; Thyroiditis; Tomography, X-Ray Computed | 2017 |
Topics: Adult; Age Distribution; Asymptomatic Diseases; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Sex Distribution; Skin Neoplasms; South Africa | 2017 |
Primary cutaneous plasmacytoma.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bortezomib; Cell Transformation, Neoplastic; Cyclophosphamide; Dexamethasone; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gene Rearrangement; Humans; Immunoglobulin Heavy Chains; Immunoglobulin M; Middle Aged; Multiple Myeloma; Plasma Cells; Positron-Emission Tomography; Proto-Oncogene Proteins c-bcl-6; Radiopharmaceuticals; Skin Neoplasms; Treatment Outcome | 2017 |
Evaluation of positron emission tomography imaging to detect lymph node metastases in patients with extramammary Paget's disease.
Topics: Aged; Aged, 80 and over; Axilla; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Paget Disease, Extramammary; Positron-Emission Tomography; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2017 |
F-18 FDG uptake in cutaneous metastases from breast cancer.
Topics: Aged; Biopsy; Breast Neoplasms; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms | 2008 |
Preoperative 18F-FDG-PET/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanoma.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Skin Neoplasms; Tomography, X-Ray Computed | 2008 |
Synchronicity.
Topics: Carcinoma, Papillary; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Melanoma; Middle Aged; Neoplasms, Multiple Primary; Neoplasms, Squamous Cell; Positron-Emission Tomography; Radiography; Scalp; Skin Neoplasms; Thyroid Neoplasms | 2008 |
[Use of fluorine-18-FDG PET-CT scans in initial management and follow-up of patients with cutaneous melanoma].
Topics: Continuity of Patient Care; Fluorodeoxyglucose F18; Humans; Melanoma; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed | 2008 |
[Role of FDG PET-CT in cutaneous melanoma].
Topics: Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Melanoma; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms | 2008 |
Diagnostic imaging in Merkel cell carcinoma: lessons to learn from 16 cases with correlation of sonography, CT, MRI and PET.
Topics: Aged; Aged, 80 and over; Carcinoma, Merkel Cell; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms; Statistics as Topic; Tomography, X-Ray Computed | 2010 |
A case of primary cutaneous diffuse large B-cell lymphoma, leg type monitored with fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Leg; Lymphoma, Large B-Cell, Diffuse; Male; Positron-Emission Tomography; Skin Neoplasms; Tomography, X-Ray Computed | 2009 |
[Merkel cell carcinoma: a rare tumor entity in an unusually young patient].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Merkel Cell; Combined Modality Therapy; Contrast Media; Disease Progression; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Knee; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Positron-Emission Tomography; Skin Neoplasms; Surgical Flaps; Whole Body Imaging | 2009 |
Dermatofibroma mimicking malignancy on integrated F-18 fluorodeoxyglucose PET-CT.
Topics: Adult; Back; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Histiocytoma, Benign Fibrous; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Ultrasonography | 2009 |
[From retroperitoneal fibrosis to gastric linitis].
Topics: Acute Kidney Injury; Aged, 80 and over; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Linitis Plastica; Male; Pleurisy; Radiopharmaceuticals; Retroperitoneal Fibrosis; Skin Neoplasms; Stomach Neoplasms; Tomography, Emission-Computed | 2009 |
Limited value of 18F-FDG PET/CT and S-100B tumour marker in the detection of liver metastases from uveal melanoma compared to liver metastases from cutaneous melanoma.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Melanoma; Middle Aged; Nerve Growth Factors; Positron-Emission Tomography; Prognosis; Retrospective Studies; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Skin Neoplasms; Tomography, X-Ray Computed; Uveal Neoplasms | 2009 |
Metastatic melanoma with multiple small bowel intussusceptions.
Topics: Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Intestine, Small; Intussusception; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed | 2009 |
S-100B concentrations predict disease-free survival in stage III melanoma patients.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Immunoenzyme Techniques; L-Lactate Dehydrogenase; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Nerve Growth Factors; Perioperative Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Skin Neoplasms; Tomography, X-Ray Computed; Young Adult | 2009 |
Unusual involvement of scalp and bilateral kidneys in an aggressive mediastinal diffuse large B cell lymphoma: documentation by FDG-PET imaging.
Topics: Fluorodeoxyglucose F18; Humans; Kidney; Kidney Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Middle Aged; Positron-Emission Tomography; Scalp; Skin Neoplasms | 2009 |
[Cholangiocarcinoma with distant cutaneous metastases].
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Skin Neoplasms; Tomography, X-Ray Computed | 2009 |
"One-stop-shop" staging: should we prefer FDG-PET/CT or MRI for the detection of bone metastases?
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms; Tomography, X-Ray Computed | 2011 |
Cost-effectiveness analysis of FDG PET-CT in the management of pulmonary metastases from malignant melanoma.
Topics: Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Melanoma; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed | 2010 |
The impact of (18)F-FDG PET-CT scanning for staging and management of Merkel cell carcinoma: results from Westmead Hospital, Sydney, Australia.
Topics: Aged; Aged, 80 and over; Carcinoma, Merkel Cell; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; New South Wales; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed | 2010 |
FDG uptake in cutaneous and subcutaneous metastases from colorectal adenocarcinoma.
Topics: Adenocarcinoma; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Skin Neoplasms; Subcutaneous Tissue; Tomography, X-Ray Computed | 2010 |
F-18 FDG PET/CT in granulomatous slack skin.
Topics: Adolescent; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Cutaneous; Male; Positron-Emission Tomography; Skin Neoplasms; Tomography, X-Ray Computed | 2010 |
A case of malignant melanoma with cardiac and gallbladder metastases detected by FDG PET-CT.
Topics: Adult; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Heart Neoplasms; Humans; Male; Melanoma; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Subtraction Technique; Tomography, X-Ray Computed | 2009 |
[Pulmonary malignant melanoma: primary or metastatic?].
Topics: Aged, 80 and over; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Lymph Nodes; Male; Melanoma; Positron-Emission Tomography; Skin Neoplasms; Tomography, X-Ray Computed | 2010 |
Utility of FDG PET/CT and brain MRI in melanoma patients with increased serum S-100B level during follow-up.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Brain Neoplasms; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Melanoma; Middle Aged; Nerve Growth Factors; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Sensitivity and Specificity; Skin Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2010 |
Positron emission tomography imaging of DMBA/TPA mouse skin multi-step tumorigenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose; Mice; Papilloma; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Skin Neoplasms; Tetradecanoylphorbol Acetate; Tomography, X-Ray Computed | 2010 |
Sentinel lymph node excision and PET-CT in the initial stage of malignant melanoma: a retrospective analysis of 61 patients with malignant melanoma in American Joint Committee on Cancer stages I and II.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sentinel Lymph Node Biopsy; Skin Neoplasms; Surgery, Computer-Assisted; Tomography, X-Ray Computed | 2010 |
Subcutaneous metastases of colorectal cancer detected with PET/CT.
Topics: Adenocarcinoma; Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Subtraction Technique; Tomography, X-Ray Computed | 2010 |
Subcutaneous panniculitis-like T-cell lymphoma with breast involvement: functional and morphological imaging findings.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Cutaneous; Magnetic Resonance Imaging; Panniculitis; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Subcutaneous Tissue; Thorax; Tomography, X-Ray Computed; Upper Extremity | 2010 |
[PET scanning for malignant melanoma and positive sentinel node diagnostics].
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2010 |
The diagnostic accuracy of 18F-FDG PET in cutaneous malignant melanoma.
Topics: Fluorodeoxyglucose F18; Humans; Melanoma; Positron-Emission Tomography; Sensitivity and Specificity; Skin Neoplasms | 2010 |
Aggressive variant of primary cutaneous anaplastic large T-cell lymphoma: a new role for 18F-FDG PET/CT.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphoma, Large-Cell, Anaplastic; Male; Positron-Emission Tomography; Skin Neoplasms; Tomography, X-Ray Computed | 2010 |
Before and after treatment 18F-FDG PET/CT images in a patient with cutaneous T-cell lymphoma.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Cutaneous; Positron-Emission Tomography; Skin Neoplasms; Tomography, X-Ray Computed | 2010 |
¹⁸F-FDG and ¹¹C-MET positron emission tomography findings of cutaneous mast cell tumor in a dog.
Topics: Animals; Antineoplastic Agents; Dog Diseases; Dogs; Fluorodeoxyglucose F18; Male; Mastocytoma; Methionine; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms | 2011 |
Sentinel lymph node excision and positron emission tomography and computed tomography in the initial stage of malignant melanoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Melanoma; Neoplasm Staging; Positron-Emission Tomography; Sentinel Lymph Node Biopsy; Skin Neoplasms; Surgery, Computer-Assisted; Tomography, X-Ray Computed | 2010 |
Melanoma imaging with highly specific PET probes: ready for prime time?
Topics: Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Melanoma; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms | 2011 |
Can (18)F-FDG PET/CT predict recurrence in patients with cutaneous malignant melanoma?
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
The value of pre operative S-100B and SUV in clinically stage III melanoma patients undergoing therapeutic lymph node dissection.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Neoplasm Staging; Nerve Growth Factors; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Skin Neoplasms; Tomography, Spiral Computed | 2011 |
Capsule endoscopy versus positron emission tomography for detection of small-bowel metastatic melanoma: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Capsule Endoscopy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidence; Intestinal Neoplasms; Intestine, Small; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; New South Wales; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Skin Neoplasms; Survival Rate; Young Adult | 2011 |
Fluorodeoxyglucose positron emission tomography fails to detect distant metastases at initial staging of melanoma patients with metastatic involvement of sentinel lymph node.
Topics: Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2011 |
False-positive positron emission tomography in patients with history of malignancy.
Topics: Adult; Anus Neoplasms; Biopsy; Breast Neoplasms; Carcinoma; Carcinoma, Lobular; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Granular Cell Tumor; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Medical Oncology; Melanoma; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence; Skin Neoplasms; Tomography, X-Ray Computed | 2011 |
AJR teaching file: incidental breast cancer detected with 18F-FDG PET/CT.
Topics: Arm; Biopsy; Breast Neoplasms; Carcinoma, Merkel Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed | 2011 |
CT-guided percutaneous biopsy of a mass lesion in the upper presacral space: a sacral transneuroforaminal approach.
Topics: Biopsy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lumbosacral Region; Melanoma; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiography, Interventional; Radiopharmaceuticals; Skin Neoplasms; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2012 |
The role of positron emission tomography with computed tomography in the follow-up of asymptomatic cutaneous malignant melanoma patients with a high risk of disease recurrence.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Skin Neoplasms; Tomography, X-Ray Computed; Young Adult | 2011 |
Guidelines for lymphoscintigraphy and F18 FDG PET scans in melanoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Melanoma; Neoplasm Staging; Positron-Emission Tomography; Practice Guidelines as Topic; Radiometry; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Skin; Skin Neoplasms | 2011 |
Use of S-100B to evaluate therapy effects during bevacizumab induction treatment in AJCC stage III melanoma.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunoenzyme Techniques; Lymph Node Excision; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Multimodal Imaging; Neoplasm Staging; Nerve Growth Factors; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Skin Neoplasms; Tomography, X-Ray Computed | 2012 |
18F-fluorodeoxyglucose uptake on positron emission tomography/computed tomography in symmetrically enlarged axillary and inguinal lymph nodes of Ofuji's papuloerythroderma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Axilla; Cyclophosphamide; Diagnostic Errors; Doxorubicin; Eosinophilia; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Folliculitis; Groin; Humans; Immunosuppressive Agents; Lymph Nodes; Lymphadenitis; Male; Multimodal Imaging; Mycosis Fungoides; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Remission Induction; Skin Diseases, Vesiculobullous; Skin Neoplasms; Tomography, X-Ray Computed; Vincristine | 2012 |
Bilateral cutaneous diffuse large B-cell lymphoma on FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Skin Neoplasms; Tomography, X-Ray Computed | 2011 |
Navigation-assisted localisation and resection of subclinical metastatic malignant melanoma of unknown primary based on 18-fluorodeoxyglcose positron emission tomography computed tomography fusion imaging.
Topics: Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Lymph Node Excision; Lymphatic Metastasis; Melanoma; Middle Aged; Multimodal Imaging; Neck Dissection; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Scalp; Skin Neoplasms; Surgery, Computer-Assisted; Tomography, X-Ray Computed; Whole Body Imaging | 2012 |
Fluorodeoxyglucose PET/CT in subcutaneous sarcoidosis mimicking cutaneous lymphoma.
Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Multimodal Imaging; Positron-Emission Tomography; Sarcoidosis; Skin Neoplasms; Tomography, X-Ray Computed | 2012 |
Early [18F]fluorodeoxyglucose-positron emission tomography responses in metastatic melanoma: what do they mean?
Topics: Female; Fluorodeoxyglucose F18; Humans; Indoles; Male; Melanoma; Radionuclide Imaging; Skin Neoplasms; Sulfonamides; Vemurafenib | 2012 |
Occult colon cancer with initial cutaneous metastatic manifestation: PET/CT detection.
Topics: Aged; Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoplasms, Unknown Primary; Positron-Emission Tomography; Skin Neoplasms; Tomography, X-Ray Computed | 2012 |
An innovative approach for locally advanced stage III cutaneous melanoma: radiotherapy, followed by nodal dissection.
Topics: Adult; Aged; Disease-Free Survival; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymph Node Excision; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Queensland; Radiopharmaceuticals; Radiotherapy, Adjuvant; Retrospective Studies; Skin Neoplasms; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Assessment of pulmonary melanoma metastases with 18F-FDG PET/CT: which PET-negative patients require additional tests for definitive staging?
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Medical Oncology; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms; Tomography, X-Ray Computed | 2012 |
A multicenter prospective evaluation of the clinical utility of F-18 FDG-PET/CT in patients with AJCC stage IIIB or IIIC extremity melanoma.
Topics: Adult; Aged; Disease Progression; Disease-Free Survival; Extremities; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Multimodal Imaging; Neoplasm Staging; Population Surveillance; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Survival Analysis; Tomography, X-Ray Computed | 2012 |
Sezary syndrome presenting with tumourous involvement of the breast detected by (18) F-fluorodeoxyglucose positron-emission tomography/computed tomography.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Immunophenotyping; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sezary Syndrome; Skin Neoplasms; Tomography, X-Ray Computed | 2012 |
PET/CT imaging of metastatic Merkel cell carcinoma to the adrenal glands.
Topics: Adrenal Gland Neoplasms; Aged; Carcinoma, Merkel Cell; Disease Progression; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Skin Neoplasms; Tomography, X-Ray Computed | 2010 |
Small bowel metastases from melanoma: does videocapsule provide additional information after FDG positron emission tomography?
Topics: Adult; Aged; Capsule Endoscopy; Duodenal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Jejunal Neoplasms; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms | 2012 |
3T-MRI, elastography, digital mammography, and FDG-PET CT findings of subcutaneous panniculitis-like T-cell lymphoma (SPTCL) of the breast.
Topics: Aged; Breast Neoplasms; Elasticity Imaging Techniques; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell; Magnetic Resonance Imaging; Mammography; Multimodal Imaging; Panniculitis; Positron-Emission Tomography; Radiographic Image Enhancement; Skin Neoplasms; Tomography, X-Ray Computed | 2012 |
Frequent relapse and irradiation strategy in primary cutaneous diffuse large B-cell lymphoma, leg-type.
Topics: Aged, 80 and over; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms | 2013 |
Role of 18F-FDG PET/CT in the diagnosis of clinically suspected Marjolin ulcer.
Topics: Adult; Aged; Burns; Carcinoma, Squamous Cell; Chronic Disease; Contracture; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Skin Diseases; Skin Neoplasms; Skin Ulcer; Tomography, X-Ray Computed | 2012 |
Whole-body MRI with diffusion-weighted sequences compared with 18 FDG PET-CT, CT and superficial lymph node ultrasonography in the staging of advanced cutaneous melanoma: a prospective study.
Topics: Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Melanoma; Neoplasm Staging; Observer Variation; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Single-Blind Method; Skin Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2014 |
Value of tumour marker S-100B in melanoma patients: a comparison to 18F-FDG PET and clinical data.
Topics: Adult; Aged; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Nerve Growth Factors; Radionuclide Imaging; Radiopharmaceuticals; Regression Analysis; Reproducibility of Results; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Skin Neoplasms | 2002 |
[Malignant melanoma: diagnostic value of F-18 FDG positron emission tomography].
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Melanoma; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Skin Neoplasms; Tomography, Emission-Computed | 2002 |
Endometrial carcinoma diagnosed by positron emission tomography: a case report.
Topics: Aged; Carcinoma; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Melanoma; Neoplasms, Multiple Primary; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed | 2002 |
Enchondroma: a benign osseous lesion with high F-18 FDG uptake.
Topics: Adult; Chondroma; Chondrosarcoma; Diagnosis, Differential; Female; Femoral Neoplasms; Fluorodeoxyglucose F18; Humans; Hyalin; Melanoma; Neoplasm Staging; Neoplasms, Second Primary; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed; Whole-Body Counting | 2002 |
Imaging of cutaneous recurrence of gastric cancer with F-18 FDG positron emission tomography.
Topics: Abdomen; Back; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Radiopharmaceuticals; Skin Neoplasms; Stomach Neoplasms; Tomography, Emission-Computed | 2002 |
18-FDG PET scan in the staging of recurrent melanoma: additional value and therapeutic impact.
Topics: Adult; Aged; Aged, 80 and over; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasms; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Skin Neoplasms; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Colonic adenomas detected by F-FDG PET.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Cutaneous; Male; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed | 2002 |
Positron emission tomographic imaging of Merkel cell carcinoma.
Topics: Aged; Carcinoma, Merkel Cell; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Radiography; Radiopharmaceuticals; Scalp; Skin Neoplasms; Tomography, Emission-Computed | 2002 |
Melanoma patients evaluated by four different positron emission tomography reconstruction techniques.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Skin Neoplasms; Tomography, Emission-Computed | 2003 |
Fluorodeoxyglucose-positron emission tomography imaging versus sentinel node biopsy in the primary staging of melanoma patients.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Skin Neoplasms; Tomography, Emission-Computed | 2003 |
PET detection of melanoma metastases in lymph nodes.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Melanoma; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 2003 |
A new animal model for the imaging of melanoma: correlation of FDG PET with clinical outcome, macroscopic aspect and histological classification in Melanoblastoma-bearing Libechov Minipigs.
Topics: Animals; Disease Models, Animal; Fluorodeoxyglucose F18; Melanoma; Neoplasm Staging; Radiopharmaceuticals; Skin Neoplasms; Swine; Swine Diseases; Swine, Miniature; Tomography, Emission-Computed | 2003 |
Metastatic malignant proliferating trichilemmal tumor detected by positron emission tomography.
Topics: Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Radiopharmaceuticals; Scalp; Skin Neoplasms; Tomography, Emission-Computed | 2003 |
Incidental detection of pigmented villonodular synovitis on FDG PET.
Topics: Back; Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hip Joint; Humans; Incidental Findings; Melanoma; Middle Aged; Pelvic Neoplasms; Radiopharmaceuticals; Skin Neoplasms; Synovitis, Pigmented Villonodular; Tomography, Emission-Computed | 2003 |
Malignant melanoma and (18)F-FDG-PET: Should the whole body scan include the legs?
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Leg; Melanoma; Neoplasm Staging; Radiopharmaceuticals; Skin Neoplasms; Tissue Distribution; Tomography, Emission-Computed | 2003 |
Fluorodeoxyglucose-positron emission tomography and sentinel lymph node biopsy in staging primary cutaneous melanoma.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Skin Neoplasms; Tomography, Emission-Computed | 2003 |
Positron emission tomography with [18F] 2-fluoro-D-2- deoxyglucose in primary cutaneous T-cell lymphomas.
Topics: Adult; Aged; Aged, 80 and over; Child; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Skin Neoplasms | 2004 |
Lymph node false-positive FDG-PET after recent surgery in primary melanoma.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 2004 |
Perineural spread of skin carcinoma to the base of the skull: detection with FDG PET and CT fusion.
Topics: Aged; Carcinoma, Squamous Cell; Cranial Nerve Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Skull Base Neoplasms; Tomography, X-Ray Computed; Trigeminal Nerve | 2004 |
[Early detection of synchronous thyroid carcinoma and malignant melanoma by fluorodeoxyglucose positron emission tomography].
Topics: Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Thyroid Neoplasms | 2003 |
Melanoma metastasis to the testis demonstrated with FDG PET/CT.
Topics: Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Melanoma; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Subtraction Technique; Testicular Neoplasms; Tomography, X-Ray Computed | 2004 |
F-18 FDG PET and Ga-67 scintigraphy in a case of fever of unknown origin with underlying cutaneous diffuse large B-Cell lymphoma.
Topics: Citrates; Female; Fever of Unknown Origin; Fluorodeoxyglucose F18; Gallium; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Rare Diseases; Skin Neoplasms | 2004 |
Merkel cell carcinoma: two case reports focusing on the role of fluorodeoxyglucose positron emission tomography imaging in staging and surveillance.
Topics: Aged; Aged, 80 and over; Carcinoma, Basal Cell; Carcinoma, Merkel Cell; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms | 2005 |
Fluorodeoxyglucose positron emission tomography in cutaneous squamous cell carcinoma: retrospective analysis of 12 patients.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms | 2005 |
Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
Topics: Adult; Aged; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 2005 |
Response monitoring by positron emission tomography during radiotherapy of a squamous cell skin carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Computer-Assisted; Skin Neoplasms; Treatment Outcome | 2005 |
Impact of [18F]fluorodeoxyglucose positron emission tomography on surgical management of melanoma patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Treatment Outcome | 2006 |
Fluorodeoxyglucose positron emission tomography for melanoma staging: refining the indications.
Topics: Decision Making; Fluorodeoxyglucose F18; Humans; Melanoma; Neoplasm Staging; Preoperative Care; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed | 2006 |
Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Tomography, X-Ray Computed | 2006 |
Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2006 |
Cutaneous metastatic lung cancer detected with 18F-FDG PET.
Topics: Adenocarcinoma; Aged; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms | 2006 |
Bilateral adrenal metastases from malignant melanoma: concordant findings on (18)F-FDG and (18)F-FDOPA PET.
Topics: Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms | 2006 |
FDG PET scan in a primitive neuroectodermal tumor.
Topics: Adult; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neuroectodermal Tumors, Primitive, Peripheral; Positron-Emission Tomography; Radiopharmaceuticals; Rare Diseases; Skin Neoplasms | 2006 |
Level of fluorodeoxyglucose uptake predicts risk for recurrence in melanoma patients presenting with lymph node metastases.
Topics: Adult; Aged; Aged, 80 and over; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Skin Neoplasms; Survival Rate | 2006 |
Acne vulgaris: false-positive finding on integrated 18F-FDG PET/CT in a patient with melanoma.
Topics: Acne Vulgaris; Adult; Back; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed | 2006 |
Clinical added-value of 18FDG PET in neuroendocrine-merkel cell carcinoma.
Topics: Aged; Carcinoma, Merkel Cell; Cell Proliferation; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Male; Middle Aged; Neuroendocrine Tumors; Positron-Emission Tomography; Skin Neoplasms | 2006 |
18F-fluorodeoxyglucose-positron emission tomography in evaluation of primary cutaneous lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Skin Neoplasms; Tomography, X-Ray Computed | 2006 |
F-18 fluorodeoxyglucose PET/CT as an imaging tool for staging and restaging cutaneous angiosarcoma of the scalp.
Topics: Aged; Biopsy; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Scalp; Skin Neoplasms; Tomography, X-Ray Computed | 2006 |
Futility of positron emission tomography and other modalities in the initial radiographic screening of patients with melanoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Medical Futility; Melanoma; Neoplasm Metastasis; Positron-Emission Tomography; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2006 |
(18)F-FDG PET/CT visualisation of tumor seeding after percutaneous radiofrequency ablation of metastases.
Topics: Catheter Ablation; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Seeding; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Subtraction Technique; Tomography, X-Ray Computed | 2007 |
FDG PET/CT demonstrates the effectiveness of isolated limb infusion for malignant melanoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Fluorodeoxyglucose F18; Infusions, Intra-Arterial; Lymphatic Metastasis; Melanoma; Melphalan; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
Gallbladder metastasis from malignant melanoma: diagnosis with FDG PET/CT.
Topics: Aged; Fluorodeoxyglucose F18; Gallbladder Neoplasms; Humans; Male; Melanoma; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Subtraction Technique; Tomography, X-Ray Computed | 2006 |
[Evaluation of efficacy and clinical impact of FDG-PET on patients with suspicion of recurrent cutaneous melanoma].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Case Management; Combined Modality Therapy; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Predictive Value of Tests; Prevalence; Prostatic Neoplasms; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Skin Neoplasms; Unnecessary Procedures | 2006 |
Primary cutaneous plasmacytoma presenting with multiple subcutaneous nodules by F-18 FDG imaging.
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Plasmacytoma; Positron-Emission Tomography; Scalp; Skin Neoplasms | 2007 |
Routine use of FDG-PET scans in melanoma patients with positive sentinel node biopsy.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Skin Neoplasms; Whole Body Imaging | 2007 |
Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Melanoma; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Reference Standards; Skin Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2007 |
F-18 FDG PET/CT imaging of a subcutaneous scalp metastasis from primary carcinoma of the thyroid.
Topics: Aged; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Scalp; Skin Neoplasms; Thyroid Neoplasms; Tomography, X-Ray Computed | 2007 |
Small bowel invagination caused by intestinal melanoma metastasis: unsuspected diagnosis by FDG-PET/CT imaging.
Topics: Diagnosis, Differential; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Intestine, Small; Leg; Melanoma; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
FDG-negative signet ring cell cancer of the stomach with FDG-positive skin metastases.
Topics: Adult; Carcinoma, Signet Ring Cell; Diagnosis, Differential; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Male; Radionuclide Imaging; Radiopharmaceuticals; Skin Neoplasms; Stomach Neoplasms | 2007 |
Utility of FDG-PET for staging in a case of mycosis fungoides.
Topics: Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Mycosis Fungoides; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms | 2007 |
F-18 FDG-avid sclerosing angiomatoid nodular transformation (SANT) of the spleen: case study and literature review.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Histiocytoma, Benign Fibrous; Humans; Hypertension; Legg-Calve-Perthes Disease; Male; Melanoma; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Skin Neoplasms; Splenectomy; Splenic Neoplasms; Tomography, X-Ray Computed | 2007 |
Metastatic malignant melanoma to the thyroid gland detected by FDG-PET imaging.
Topics: Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Melanoma; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Thyroid Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2007 |
F-18 fluorodeoxy-D-glucose positron emission tomography scan in the initial evaluation of patients with a primary melanoma thicker than 4 mm.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2007 |
F-18 FDG PET as an imaging tool for detecting and staging metastatic basal-cell carcinoma.
Topics: Carcinoma, Basal Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed; Whole Body Imaging | 2007 |
Hibernoma: 18F FDG PET/CT imaging.
Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lipoma; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed | 2007 |
Whole body positron emission tomography in follow-up of high risk melanoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Whole Body Imaging | 2007 |
High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Tomography, X-Ray Computed | 2007 |
Clinical value of including the head and lower extremities in 18F-FDG PET/CT imaging for patients with malignant melanoma.
Topics: Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Head; Humans; Leg; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Retrospective Studies; Skin Neoplasms; Tomography, X-Ray Computed | 2007 |
S-100B and FDG-PET/CT in therapy response assessment of melanoma patients.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Nerve Growth Factors; Positron-Emission Tomography; Radiopharmaceuticals; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Skin Neoplasms; Tomography, X-Ray Computed | 2007 |
Desmoplastic malignant melanoma evaluated with 18F-fluorodeoxyglucose positron emission tomography-computed tomography and sentinel lymph node biopsy.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2008 |
Multimodality approach of perioperative 18F-FDG PET/CT imaging, intraoperative 18F-FDG handheld gamma probe detection, and intraoperative ultrasound for tumor localization and verification of resection of all sites of hypermetabolic activity in a case of
Topics: Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Intraoperative Care; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Thigh; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging | 2008 |
Disseminated extranodal NK/T-cell lymphoma, nasal type, with multiple subcutaneous nodules: utility of 18F-FDG PET in staging.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Neoplasm Staging; Nose Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms | 2008 |
Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma.
Topics: Deoxyglucose; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Pilot Projects; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 1993 |
Normal thymic uptake of FDG on PET imaging.
Topics: Adolescent; Adult; Child; Child, Preschool; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Reference Values; Skin Neoplasms; Thymus Gland; Tomography, Emission-Computed | 1996 |
Detection of unknown occult primary tumors using positron emission tomography.
Topics: Adult; Aged; Bone Neoplasms; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed | 1998 |
Malignant melanoma staging using whole-body positron emission tomography.
Topics: Aged; Animals; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Prospective evaluation of 2-[18F]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma.
Topics: Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 1998 |
Effectiveness of positron emission tomography for the detection of melanoma metastases.
Topics: Diagnostic Errors; Fluorodeoxyglucose F18; Humans; Melanoma; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 1998 |
[Muscle uptake of 18FDG in positron emission tomography].
Topics: Antineoplastic Agents; Anxiety; Breast Neoplasms; Diazepam; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Muscle Contraction; Muscle Relaxants, Central; Muscle, Skeletal; Peripheral Nervous System Diseases; Radiopharmaceuticals; Skin Neoplasms; Tissue Distribution; Tomography, Emission-Computed | 1998 |
Positron emission tomography plus serum TA90 immune complex assay for detection of occult metastatic melanoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Biomarkers, Tumor; Enzyme-Linked Immunosorbent Assay; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 1998 |
Planar coincidence scintigraphy and PET in staging malignant melanoma.
Topics: Adult; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Melanoma; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 1998 |
PET evaluation of therapeutic limb perfusion in Merkel's cell carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Carcinoma, Merkel Cell; Chemotherapy, Cancer, Regional Perfusion; Female; Fluorodeoxyglucose F18; Humans; Leg; Melphalan; Radiopharmaceuticals; Recurrence; Skin Neoplasms; Tomography, Emission-Computed; Tumor Necrosis Factor-alpha | 1998 |
Primary staging and follow-up of high risk melanoma patients with whole-body 18F-fluorodeoxyglucose positron emission tomography: results of a prospective study of 100 patients.
Topics: Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Melanoma; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Risk; Skin Neoplasms; Tomography, Emission-Computed | 1999 |
FDG PET-negative liver metastases of a malignant melanoma and FDG PET-positive hurthle cell tumor of the thyroid.
Topics: Adenoma, Oxyphilic; Aged; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Melanoma; Neoplasms, Multiple Primary; Radiopharmaceuticals; Skin Neoplasms; Thyroid Neoplasms; Tomography, Emission-Computed | 1999 |
Use of [F]-fluorodeoxyglucose positron emission tomography in monitoring response of recurrent neurotropic desmoplastic melanoma to radiotherapy.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Mandibular Neoplasms; Melanoma; Mouth Neoplasms; Neoplasm Recurrence, Local; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed | 2000 |
Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of silent metastases from malignant melanoma.
Topics: Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 2000 |
The value of positron emission tomography scanning in the detection of subclinical metastatic melanoma.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 2000 |
Contribution of whole body F-18-FDG-PET and lymphoscintigraphy to the assessment of regional and distant metastases in cutaneous malignant melanoma. A pilot study.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Pilot Projects; Radiopharmaceuticals; Reproducibility of Results; Skin Neoplasms; Tomography, Emission-Computed | 2000 |
Positron emission tomography scanning in malignant melanoma.
Topics: Fluorodeoxyglucose F18; Humans; Melanoma; Neoplasm Staging; Prospective Studies; Skin Neoplasms; Tomography, Emission-Computed | 2000 |
Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanoma.
Topics: Adult; Aged; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Melanoma; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 2000 |
Fluor-18-fluorodeoxyglucose positron emission tomography (FDG-PET) in malignant melanoma. Diagnostic comparison with conventional imaging methods.
Topics: Abdomen; Adolescent; Adult; Aged; Diagnostic Imaging; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Mass Screening; Melanoma; Middle Aged; Neoplasm Staging; Neoplastic Cells, Circulating; Radiopharmaceuticals; Retrospective Studies; Skin Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography; Whole-Body Irradiation | 2000 |
Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of micrometastases of primary cutaneous malignant melanoma.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Prospective Studies; Sentinel Lymph Node Biopsy; Skin Neoplasms; Tomography, Emission-Computed | 2001 |
Cervical lymph node sarcoidosis as a pitfall in F-18 FDG positron emission tomography.
Topics: Aged; Diagnosis, Differential; Ear, External; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Melanoma; Neck; Radiopharmaceuticals; Sarcoidosis; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 2001 |
Elevated FDG uptake in the lactating human breast.
Topics: Adult; Breast; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lactation; Melanoma; Neoplasm Staging; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 2001 |
Evaluation of high-risk melanoma: comparison of [18F]FDG PET and high-dose 67Ga SPET.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Citrates; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gallium; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Whole-Body Counting | 2002 |
[Diagnosis of metastasis of malignant melanoma in the thyroid gland with f18-FDG PET scan].
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Skin Neoplasms; Thyroid Neoplasms; Tomography, Emission-Computed | 2002 |
[The role of PET scan in the diagnosis of malignant melanoma].
Topics: Adult; Aged; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 2002 |